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IV. ABSTRACT 
Illegible written prescriptions and “Doctor’s handwriting” may have been synonymous, but 
this stereotype has begun to change with the gradual uptake of e-prescriptions.  These e-
prescriptions are electronically captured and delivered prescriptions, and are touted as the 
solution to the many medical risks caused by written prescriptions.  Whilst there is published 
support for the benefits of e-prescriptions, the uptake of e-prescribing has been too gradual 
for all patients to enjoy these benefits.  The inadequate research into physicians’ adoption of 
e-prescribing systems presents a need for further study in this area, in an effort to improve the 
general use of these systems. 
 
Based on a review of literature, this study proposes six factors which may explain physicians’ 
intentions to use e-prescribing systems.  These factors are based upon the Unified Theory of 
Acceptance and Use of Technology (UTAUT).  This model is extended in this study by 
Social Dominance Theory, Commitment-Trust Theory and the Product Evaluation Model.  
Quantitative data was collected to test the proposed hypotheses.  This data was gathered from 
physicians who have had some exposure to an e-prescription system.  72 usable responses 
were obtained for this study. 
 
The results of the study suggest that Performance Expectancy and Price Value have the 
highest influence on Behavioural Intention.  Effort Expectancy and Social Influence had no 
direct influence on Behavioural Intention when in the presence of other variables, but they, 
along with Trust, had an indirect effect on Behavioural Intention through Performance 
Expectancy.  Surprisingly, Social Dominance Orientation was not found to have an influence 
on Behavioural Intention.  Implications, contributions and further research are discussed. 
 
 
Keywords: E-prescribing, e-prescription, physician, acceptance, UTAUT, Social Dominance 
Theory, Commitment-Trust Theory, Product Evaluation Model 
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CHAPTER 1:   INTRODUCTION 
1.1 Context of the Study 
1.1.1 Background 
Prescription errors, whether in the writing or reading of written prescriptions, can account 
for up to 7000 patient deaths and 1.3 million patient injuries in the United States annually 
(Werner, Nelson & Boehm-Davis, 2012; Ammenwerth, Schnell-Inderst, Machan & 
Siebert, 2008).  The likelihood of these prescription errors occurring may, however, be 
reduced when computer systems in medical practices are involved in prescribing 
medicine through the electronic capture of patient medical scripts (Kaushal, Kern, 
Barrón, Quaresimo & Abramson, 2010; Ammenwerth et al., 2008).  Electronic 
prescribing, or e-prescribing, is the use of computers to enter, modify, review, issue 
and/or transmit medication prescriptions (Johnson & FitzHenry, 2006).  This electronic 
practice may be used in place of the regular written prescription, where instead of a paper 
form being filled out by the physician, an online form is filled in.  The resultant e-
prescription is then made available to the dispensing pharmacist in electronic or printed 
form.  Due to the electronic element, an e-prescription no longer falls under the ills of 
poor handwriting or pharmacist interpretation, and can be reprinted at will if lost by the 
patient.   
 
The prescription process, which occurs between the physician, the patient and the 
pharmacist, is initiated by the physician when consulting with the patient.  The physician 
is the primary agent in this prescription process and plays a critical role in the decision to 
use or not to use e-prescriptions (Smith, 2006).  Unfortunately, it has been argued that e-
prescribing won’t be adopted very quickly by physicians (Crosson, Etz, Wu, Straus, 
Eisenman & Bell, 2011; Smith, 2006; Chin, 2003).  As a consequence this study will 
focus on the physician. 
1.1.2 Written Prescription Risks, E-prescribing Benefits 
Writing prescriptions is fundamental to every physician’s day (Blair, 2006). The 
repetitive nature of this task, however, does not discount the risks to the health of the 
patient involved, often with prescriptions which are either incorrectly filled out by the 
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physician, or incorrectly interpreted by the pharmacist.  This may result in incorrect 
medicines or doses being dispensed, or incompatible medicines being dispensed together, 
creating a potential hazard for patients and their health (Ammenwerth et al., 2008). 
 
These prescription risks may be lowered by making use of the potential benefits of e-
prescriptions, which include: 
• Overcoming the problem of illegible written prescriptions and the consequent 
dispensing problems such as incorrect dispensing or repeat call backs to the 
physician. 
• Lowered rate of adverse effects, by up to 86% (Kaushal et al., 2010), from mixing 
incompatible drugs or basic physician errors being lowered through decision 
support and drug safety alerts on the system. 
• Accurate patient drug history of past prescriptions from multiple physicians for 
drug history and complications, where available. 
(Tamblyn, Huang, Kawasumi, Bartlett, Grad, Jacques, Dawes, Abrahamowicz, 
Perreault, Taylor, Winslade, Poissant & Pinsonneault, 2006; Ammenwerth et al., 
2008; Devine, Hollingworth, Hansen, Lawless, Wilson-Norton, Martin, Blough & 
Sullivan, 2010; van Doormaal, van den Bemt, Zaal, Egberts, Lenderink, Kosterink, 
Haaijer-Ruskamp & Mol, 2009; Halamka, Aranow, Ascenzo, Bates, Berry, Debor, 
Fefferman, Glaser, Heinold, Stanley, Stone, Sullivan, Tripathi & Wilkinson, 2006; 
van der Sijs, Aarts, Vulto & Berg, 2006).   
 
Given how e-prescribing systems can reduce the risks associated with written 
prescriptions, it is critical that e-prescriptions are adopted with a view to reduce these 
health risks, potentially lowering the patient death rate from these errors.  
1.1.3 Additional E-prescribing Benefits 
E-prescribing goes beyond dealing with the prevention of the potential health risks 
caused by errors in written prescriptions, bringing additional, second order, benefits.  
These include cost and time savings, for both patients and medical practitioners.  Patients 
benefit through broader generic drug choice, potentially fewer days in hospital or even 
fewer admissions to hospital altogether (Halamka et al., 2006).  Savings are found for 
medical practitioners when pharmacists no longer need to call them back on prescriptions 
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due to illegible handwriting, or where the physician can be bypassed altogether for 
prescription refills pre-defined on the system (Tamblyn et al., 2006, Halamka et al., 
2006).  E-prescription systems also allow for better tracking of leaked prescriptions, 
indicating whether patients are in fact going to the pharmacist and obtaining the 
medication prescribed by the physician (Halamka et al., 2006). 
1.1.4 Acceptance of E-prescriptions 
E-prescribing is at least ten years old (Wang, Patel, Schueth, Bradley, Wu, Crosson, 
Glassman & Bell, 2009), and given the potential benefits it is surprising that the 
acceptance of e-prescriptions by physicians has not increased as quickly as it could 
(Mäkinen, Rautava, Forsström & Äärimaa, 2011).  Some explanations for low adoption 
may be due to e-prescriptions least benefiting the physician, with the financial cost of the 
system placed to their account (Chin, 2003; Crosson et al., 2011).  Furthermore, some 
studies suggest e-prescriptions may cause a physician to spend longer working with the 
prescription than using written prescriptions might do (Eslami, Abu-Hanna & de Keizer, 
2007; Devine et al., 2010).  Although steps are being put in place to encourage physicians 
to adopt e-prescriptions, such as financial incentives and possible legislative force in 
some countries (Crosson et al., 2011), further focus needs to be placed on understanding 
physician acceptance of e-prescription systems, especially where physicians have not had 
prior exposure to such systems.  Given that the current use of e-prescriptions is not 
mandatory, the study of physician acceptance of e-prescriptions will take place in a 
voluntary setting.  South Africa has a long standing shortage of doctors, with no expected 
improvement in the short term (Breier, 2008).  The use of e-prescribing in South Africa 
may help alleviate the impact of having such a shortage of doctors.  This could be 
achieved through prescribing efficiencies which allow physicians to see more patients per 
day, and through lowered dispensing errors which would lessen the need for additional, 
corrective treatment of previously treated patients.  Based on the potential benefits e-
prescribing may bring to South Africa, it is a useful test context for this study. 
1.2 Problem Statement 
1.2.1 Main Problem 
• To what extent do physicians intend to use e-prescribing systems? 
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1.2.2 Sub-Problems 
• To what extent does the perceived change in performance from e-prescribing 
affect physicians’ intention to use an e-prescribing system? 
• To what extent does the perceived usability of an e-prescribing system affect 
physicians’ intention to use such a system? 
• To what extent does the degree to which a physician is socially influenced to 
use an e-prescribing system affect the physician’s intention to use such a 
system? 
• To what extent does the degree to which a physician is social dominance 
orientated affect the physician’s intention to use an e-prescribing system? 
• To what extent does the perceived price value of an e-prescribing system 
affect physicians’ intention to use such a system? 
• To what extent does the perceived change in performance mediate the 
relationship between perceived usability and physicians’ intention to use the 
system? 
• To what extent does the perceived change in performance mediate the 
relationship between social influence and physicians’ intention to use the 
system? 
• To what extent does the perceived change in performance mediate the 
relationship between confidence in the system’s reliability and physicians’ 
intention to use the system? 
1.3 Research Model 
This section presents the model of the study, which will be further elaborated upon in the 
next chapter. 
This study makes use of the Unified Theory of Acceptance and Use of Technology 
(UTAUT) of Venkatesh, Morris, Davis & Davis (2003).  The existing model uses 
Behavioural Intention (BI) as the dependent variable, with Performance Expectancy (PE), 
Effort Expectancy (EE), and Social Influence (SI) as independent variables of BI.     
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In the context of physicians’ intention to use e-prescribing systems the model is extended 
by adding Trust in technology, Social Dominance Orientation (SDO) and Price Value as 
independent variables.  The adapted model can be found in Figure 1.1. 
 
 
Figure 1.1 - Model of factors and their relationships with Intention, adapted from Venkatesh et al. (2003). 
 
1.4 Significance of the Study 
1.4.1 Theoretical Impact 
This study extends the traditional UTAUT by adding Trust as an independent variable of 
intention to use.  This may introduce the concept that before adopting a technology, a 
potential user needs to believe the technology will demonstrate the expected effects.  The 
study also extends UTAUT by introducing Social Dominance Orientation (SDO).  If it is 
found that higher SDO levels explain physicians’ lower intention to use e-prescribing 
systems it may indicate why other factors, such as Performance Expectancy (PE) and 
Effort Expectancy (EE), did not necessarily lead to higher intentions to use e-prescription 
systems.  This study may shed further light on the impact of Price Value upon 
individuals’ intention to use a system, and how these potential users consider the 
monetary cost of a system prior to use.   
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1.4.2 Practical Impact 
An improved understanding of e-prescribing acceptance amongst physicians may assist 
practically in successfully rolling out e-prescribing systems.  Focus may need to be 
placed on addressing change through the social dominance orientation of an individual, 
such as having another member from the same professional or dominance group initiate 
the change rather than an individual from an out-group.  Thus an improvement in 
intention to use may occur when other physicians encourage physicians to use the system, 
rather than those outside of the physician profession.  This makes use of positive social 
influence to encourage the use of e-prescribing, while at the same time preventing any 
possible negative effects brought in through higher social dominance orientation.  
Through this it is expected that an improved uptake of e-prescribing may benefit patients 
and lower the incidence of prescription errors. 
 
Further understanding may be gained upon the role of trust in technology, and how it may 
affect the perceived performance improvements of an e-prescribing system.  This may 
lead to subsequent efforts to build up trust in the technology through long term stability 
and reliability in order to encourage use.   
 
The study may also indicate that the price of a system could have an impact on 
physicians’ intention to use e-prescriptions, indicating an additional area to focus on to 
encourage the use of e-prescription.  This is especially relevant as it is the physicians who 
need to pay the bill for these systems. 
1.5 Aims of the Study 
Despite e-prescribing being available for more than ten years, the uptake of e-prescribing 
has not reached levels expected (Mäkinen et al., 2011).  This may be due to lower 
acceptance by physicians, who play a pivotal role in adoption of such systems.  
Consequently, there is a need to better understand why physicians, in a non-compulsory 
setting, may choose to accept e-prescribing.  Once these factors are better understood, 
steps can be taken in practice to address any concerns around them with physicians, in 
order to maximise adoption of e-prescribing systems, potentially resulting in lowered 
risks currently found with handwritten prescriptions.  The theoretical findings may gain 
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further understanding around physicians’ decisions to use e-prescriptions, a context not 
yet highly researched. 
 
This study shall construct hypotheses, after which it will collect and measure empirical 
data to test the hypotheses. 
1.6 Delimitations of the Study 
This study is limited to physicians who have had some interaction with e-prescribing 
systems.  This is to allow them to have formed an opinion on e-prescribing based on 
personal exposure.  For this to occur, the respondents would need to be those who are 
linked to an existing system.  Health-Soft, a company based in South Africa, is one such 
provider of an e-prescribing system, and would be able to supply a database of physicians 
who have had personal exposure to their e-prescribing system. 
1.7 Chapter Summary and Structure of Report 
This chapter considers the potential mitigation of risks surrounding written prescriptions 
and additional benefits made available through e-prescribing systems, contrasted against 
the lower than expected uptake of these systems by physicians.  The study is initiated to 
measure the extent to which physicians intend to use e-prescribing systems, and the 
extent to which the intention of physicians is affected by various factors.  These factors 
are perceived change in performance, perceived usability, the degree to which the 
physician feels socially obligated to change, the social dominance orientation of the 
physician, the level of confidence in the system and the perceived monetary value of the 
system. 
 
The subsequent chapters will include: 
Chapter 2 – Literature review: This chapter will consider prior research in the 
field.  It will explain the theoretical underpinnings of the study, and also describe 
the conceptual model and hypotheses. 
Chapter 3 – Research methods: This chapter will describe the specific questions 
and data collection process in order to test the hypotheses in the chosen model. 
Chapter 4 - Data analysis: This chapter will collate the surveyed data, 
demonstrating the validity of the hypotheses through statistical analysis. 
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Chapter 5 –Discussion: This chapter will comment on the statistical results from 
the data collected, linking to prior research. 
Chapter 6 – Conclusion: This chapter will summarise the previous chapters, and 
consider the results, giving suggestions for further study. 
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CHAPTER 2:   LITERATURE REVIEW 
2.1 Chapter Introduction 
This chapter provides a literature review of the intention of physicians to use e-
prescribing systems, with a view of exploring what factors may support this intention.  
The proposed model to explain physicians’ intention to use these systems will be 
described, covering the factors of Performance Expectancy, Effort Expectancy, Social 
Influence, Social Dominance Orientation, Price Value and Trust in technology.  These are 
derived from four theoretical underpinnings, being the Unified Theory of Acceptance and 
Use of Technology, Trust in Technology, Social Dominance Theory and the Product 
Evaluation Model.   
 
The chapter will begin by examining the existing research into adoption of e-prescribing 
systems, after which it will explore the theoretical background of the context, and present 
a model and hypotheses based upon the theoretical underpinnings. 
2.2 Theoretical Background 
2.2.1 Definitions and Explanation 
Electronic Health Records (EHRs) have provided the platform for a number of 
information systems for physicians (Simon, Soran, Kaushal, Jenter, Volk, Burdick, 
Cleary, Orav, Poon & Bates, 2009).  These information systems include computerised 
provider order entry systems (CPOE), the most common of which are e-prescription 
systems (Bell, Cretin, Marken & Landman, 2004; Simon et al., 2009; Devine et al., 2010; 
Schade, Sullivan, De Lusignan & Madeley, 2006).  E-prescribing is the use of computers 
to enter, modify, review, issue and/or transmit medication prescriptions (Johnson & 
FitzHenry, 2006).  This process replaces the written prescription, where a physician may 
use a computer system to capture and confirm medicinal dosage, details and instructions 
for a patient.  The dispensing pharmacist may obtain these details electronically, with 
these details then being viewed on a screen or printed out.  In addition to its primary use 
of replacing written prescriptions, e-prescribing systems provide decision support through 
safety warnings for inter-medicine incompatibilities (Johnson, Ho, Cala & Davidson, 
2010), medicine recall notices, patients’ medicine history, and allergic reactions (van der 
Sijs et al., 2006).   
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Image 2.1 is an example of an e-prescribing system interface.  The main part of the 
screen in this example allows the physician to select a medication to prescribe, along with 
its strength and delivery method.  This example also provides inter-drug compatibility 
details, patient medication history and it supplies fields for extra information to be 
recorded such as special instructions from the physician. 
 
 
Image 2.1 – An example of an e-prescribing system interface, taken from iMedx (http://www.imedx.com/turborx) 
 
E-prescription systems have been in use for over a decade (Wang et al., 2009), with these 
systems predominantly being used in the USA (Fischer, Vogeli, Stedman, Ferris & 
Weissman, 2007), but are also used in the UK (Smith, 2006), Sweden (Hellström, Waern, 
Montelius, Åstrand & Petersson, 2009), Canada (Pare, Sicotte & Jacques, 2006), 
Australia (Smith, 2006), Singapore and a number of other countries (Ammenwerth et al., 
2008).  The European Union has also identified e-prescriptions as an important strategic 
policy for the coming years (Kierkegaard, 2013).   
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E-prescription systems have been shown to lower prescription errors by up to 40% (van 
Doormaal et al., 2009). Unfortunately, notwithstanding the benefits of e-prescription 
systems, e-prescribing has not reached the level of use initially hoped for (Mäkinen et al., 
2011).  Some of the reasons given for slow adoption of e-prescription systems are the 
cost of the systems and a low trust in the technology by physicians (Smith, 2006), and 
concerns of the additional time it takes to use such systems in day to day processes 
(Devine et al., 2010).   
2.2.2 Contributions and Shortcomings of Prior Research 
In order to identify prior research on physicians’ adoption of e-prescribing, two online 
databases, EBSCOhost and ProQuest, were searched with the following search strings: 
“Electronic Prescription”, “Electronic Prescribing”, “e-prescribing”, “e-prescription”, 
“eprescribing” and “eprescription”.  The results were checked by title and abstract for 
studies involving physician acceptance of e-prescription systems.  Due to a larger ratio of 
results coming from the Journal of the American Medical Informatics Association, a 
further search with the same strings was done on that particular journal.  The final result 
list counted 39 related journal articles, seven of which focussed on physicians and their 
acceptance of e-prescribing.  Further constraints on the search strings were unnecessary 
as they returned the same results, albeit less in number.   
 
These e-prescribing studies followed two distinct approaches, a theoretical acceptance 
model based approach (Tamblyn et al., 2006; Wang et al., 2009; Pare et al., 2006; 
Boonstra, 2003) and a descriptive research approach (Simon et al., 2009; Fischer et al., 
2007; Pagán, Pratt & Sun, 2009).  The acceptance model research made use primarily of 
the Technology Acceptance Model (TAM) from the study of Davis (1989), with one 
instance of borrowed constructs from the Unified Theory of Acceptance and Use of 
Technology (UTAUT) of Venkatesh et al. (2003). 
 
The previous e-prescribing studies were based upon Davis’ (1989) argument that users’ 
perceptions of usefulness (PU) and ease of use (PEOU) of a technology have a 
relationship with the acceptance and intention to use that technology.  This argument, 
based on PU and PEOU, has been tested with some success in the general health care 
context (Holden & Karsh, 2009), and was corroborated within this context of physicians’ 
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acceptance of e-prescribing through studies by Boonstra (2003), Pare et al. (2006) and 
Tamblyn et al. (2006).  Wang et al. (2009) used the UTAUT model and demonstrated 
results which suggested that both performance expectancy (PE) and effort expectancy 
(EE) had an association with physicians’ acceptance of e-prescribing systems.  If one 
accepts the argument that PE and EE are conceptually synonymous with PU and PEOU 
(Venkatesh et al., 2003; Holden & Karsh, 2009), then it can be put forward that all four 
acceptance model based studies show that PU (PE) and PEOU (EE) may have a 
relationship with physicians’ acceptance of e-prescription systems. 
 
Notwithstanding the strong corroboration between studies on PU and PEOU, Boonstra 
(2003) argues that PU and PEOU in isolation are not sufficient to explain acceptance in 
the e-prescribing context, with additional factors such as social or environmental factors 
being suggested for future investigation.  In support of this argument, some studies 
suggest other factors, such as concerns whether the systems will function as they are 
expected to do (Rosenbloom, 2006; Tamblyn et al., 2006), financial cost factors 
(Halamka et al., 2006), and various other potential factors (Fischer et al., 2007; Simon et 
al., 2009).  Boonstra’s (2003) observations that PE and PEOU are not sufficient to 
explain acceptance of e-prescribing may tie in with Davis, Bagozzi & Warshaw (1989, 
pg. 989) when they point out that PU and PEOU are in place to “provide a foundation for 
studying the impact of external variables on user behaviour”.  It thus follows that further 
external factors need to be investigated in the context of physicians’ acceptance of e-
prescribing. 
 
The standard UTAUT model, which builds partly upon TAM, includes other variables 
with PU and PEOU.  Within the e-prescribing context, however, existing literature has 
not fully explored UTAUT, with only one study found which made use of it (Wang et al., 
2009), albeit focussing mainly on PE (PU) and EE (PEOU).  Consequently it is suggested 
that existing literature does not adequately account for, nor synthesise, additional factors 
into a broader understanding of the context beyond PU and PEOU.  These shortcomings 
suggest a need for further research to test existing and additional concepts which may 
better account for why physicians might choose to accept e-prescribing.  A summary of 
these contributions and shortcomings can be found in Table 2.1. 
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Table 2.1: Summary of Contributions and Shortcomings   
Reference  Theoretical Model  Contribution  Shortcoming 
Boonstra (2003)  TAM  
- Supported PU and PEOU as having 
positive relationships with 
acceptance 
- Highlighted external factors (time 
delays, cultural factors, financial 
factors, environmental factors) 
 
- Qualitative, unable to measure 
relative strengths. 
- Time delays may need to fall 
under PU  
Tamblyn et al. (2006)  TAM  
 
- Supported PU and PEOU as having 
positive relationships with 
acceptance 
- Experience of use on a computer is 
considered. 
 
- Low respondent rate, study may 
not be generalisable. 
- Does not seem to test hypotheses 
Wang et al. (2009)  
UTAUT (limited use of 
constructs)  
- Supported PE (PU) and EE (PEOU) 
as having positive relationships with 
acceptance 
 
 
- Little info given on moderators 
and other factors found within 
UTAUT, such as social influence. 
- Counted non-users as those which 
stopped using the system, 
excluding those who had no 
behavioural intention to start.  The 
moderators are different between 
these two different variables.  
Pare et al. (2006)  TAM  
 
- Psychological ownership shown to 
have a strong positive relationship 
with PU and PEOU.  
- Supported PE (PU) and EE (PEOU) 
as having positive relationships with 
acceptance 
 
- Item factor loading caused the 
psychological results to be viewed 
with caution, and are excluded 
from this study 
Simon et al. (2009)  
 
Study based on practice 
characteristics and 
physician perceptions post 
adoption. 
 
 
- Physician’s attributes which may be 
indicative of adoption.  
 
 
- Descriptive only 
- Seeks to understand acceptance 
through human and practice 
attributes rather than system 
attributes 
    
 
 
 
 
2.3 Theoretical Framework 
Wang et al. (2009) address some of the variables presented in Table 2.1 by making use of 
UTAUT, such as social influence and facilitating conditions.  Wang et al. (2009), 
however, make inadequate use of UTAUT by focussing only on PE (PU) and EE 
(PEOU), which discounts any explanative power UTAUT may have over TAM in 
explaining acceptance of e-prescribing systems.  It has been argued that the UTAUT 
model explains up to 70% of general user acceptance and use of technology (Venkatesh 
et al., 2003).  This model has been tested across cultures (Im, Hong & Kang, 2011) and 
 14 
 
has been used multiple times in the medical technology acceptance context (Holden & 
Karsh, 2009).  UTAUT focuses on perceptions of individuals to understand their 
subjective view of a system in order to explain their subjective intention to use a system.  
This model proposes that four independent variables, being PE, EE and Social Influence 
(SI) are factors of the dependent variable of behavioural intention (BI).  The variable 
Facilitating Conditions (FC) is included in the standard UTAUT, but this is a factor of 
actual Use Behaviour, rather than Behavioural Intention (Venkatesh et al., 2003; Ajzen, 
1991).  Due to this study focussing on Behavioural Intention (as discussed later in this 
chapter), rather than actual use behaviour, FC will be excluded in this study.   
 
The moderators within this model affect the pertinence of the relationship between the 
independent and dependent variables.  These are gender, age, experience on the system 
and voluntariness of use.  Some studies which focussed on UTAUT placed less emphasis 
on the moderators (e.g. Im et al., 2011), including studies within the medical context 
(Holden & Karsh, 2009).  Wang et al. (2009) supported the findings of these studies 
when it found no support for the moderating role of age, gender and experience in the e-
prescribing context.  In following of these previous results, and in an effort to gain 
simplicity in the model, these moderators will not form part of this study, but age and 
gender will be retained for demographic information. 
 
Venkatesh et al. (2003) devised UTAUT by comparing eight similar acceptance models.  
Two of these models, TAM (Davis, 1989), and TAM2 (Venkatesh & Davis, 2000), 
included mediating relationships of PE between EE and BI, and between SI and BI.  
These relationships are excluded from the original UTAUT, thus precluding possible 
effects brought about by these relationships.  The existence of these relationships between 
EE and PE, and SI and PE are, however, demonstrated and supported again in TAM3 
(Venkatesh & Bala, 2008).  The relationships between EE and PE, and between SI and 
PE, will be investigated in this study due to the support of these relationships in 
UTAUT’s underlying models (TAM, TAM2) and later models (TAM3). 
 
The inclusion of Social Influence, or the positive influence on one’s behaviour brought 
upon by important others, does not take into account the possible negative influence 
brought about by unimportant others.  This social behavioural phenomenon, named social 
dominance orientation or SDO, is defined by Pratto, Sidanius, Stallworth & Malle (1994, 
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pg. 742) as “the extent to which one desires that one's in-group dominate and be superior 
to out-groups”.  This describes an individual’s general attitude toward inter-group 
relations.  This attitude could, in turn, drive that individual to seek, join and reinforce 
either hierarchical-enhancing or hierarchical-attenuating ideologies, social structures or 
professional structures (Pratto et al., 1994).  SDO further infers that individuals may react 
in the opposite way to what out-group members suggest they should (Pratto et al., 1994). 
This theory has regularly been used when measuring power-based views of specific 
societal groups such as race, religion and culture (e.g. Ho; Sidanius; Pratto; Levin; 
Thomsen; Kteily & Sheehy-Skeffington, 2012), but it is also argued that SDO is a 
generalisable orientation across contexts (Kteily, Ho & Sidanius, 2012), which includes 
the professional dominance of physicians (Freidson, 2007).  A demonstration of this 
generalisability is the use of SDO in corporate hierarchy dominance (e.g. Kwesiga, 2006; 
Magee & Galinsky, 2008).  Physicians have been linked to higher levels of SDO 
(Freidson, 2007, Pratto et al., 1994), and individuals who have high levels of SDO are 
more likely to resist changes which alter the status quo (Sidanius & Pratto, 1999), such as 
physicians being resistant to changing their methods to use e-prescribing systems (Smith, 
2006).  In supporting the link between physicians and SDO, it has been demonstrated that 
physicians are less likely to take on new systems when these systems are suggested by 
individuals from other professions, i.e. not part of the legitimate in-group (Gollop, 
Whitby, Buchanan & Ketley, 2004; Davies, Powell & Rushmer, 2007).  This may 
indicate that physicians are less likely to adopt new systems due to a potentially high 
SDO level.  The UTAUT model will thus be extended by adding SDO in the context of 
physicians’ intention to use e-prescribing systems. 
 
The use of PE within UTAUT measures whether the technology may be useful in its 
functional state, but it does not necessarily measure whether it is trusted to remain 
functional, and perform that useful function reliably and without error.  Trust, in relation 
to acceptance, was put forward by Gefen, Karahanna & Straub (2003), who suggest that 
trust in the vendor who provides a technology may lead to adoption of that technology.  
The approach of Gefen et al. (2003), however, implies that the trust is based on user 
perceptions of the vendor rather than the technology in question.  An alternative view of 
trust which focuses on the actual service is defined by Garbarino & Johnson (1999, pg. 
71) as “confidence in the quality and reliability of the services offered”.  This is based 
upon Commitment-Trust Theory (Morgan & Hunt, 1994).  Support for this is found in the 
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e-prescribing context by Smith (2006) who points to physicians’ lack of trust in new 
technology as a hindrance to their adoption. Consequently, Trust in technology will 
extend UTAUT in this study.   
 
UTAUT does not address the concerns which exist around the funding of e-prescription 
systems, especially as physicians generally need to carry the financial burden (Crosson et 
al., 2011; Chin, 2003; Smith, 2006; Halamka et al., 2006).  This potential stumbling block 
to the use of e-prescriptions may be explained by the product evaluation model (Dodds, 
Monroe & Grewal, 1991).  This model aims to explain that individuals are more likely to 
use a product if they perceive that the value of the product outweighs the monetary cost.  
It thus follows that there is a relationship between an individual’s perception of the Price 
Value (PV) of the product and any subsequent intention to use a product.  The use of the 
product evaluation model has been used successfully in prior acceptance research 
(Venkatesh, Thong & Xu, 2012; Chu & Lu, 2007), and will extend UTAUT in this study.   
 
The research into the intention of physicians to use e-prescribing systems will therefore 
measure the relationship between BI and PE, EE and SI, based on UTAUT (Venkatesh et 
al., 2003), and will be extended by SDO (Pratto et al., 1994), Trust (Morgan & Hunt, 
1994) and PV (Dodds et al., 1991). 
 
A summary of the theoretical underpinnings can be found in Table 2.2. 
 
Table 2.2: Summary of Theoretical Underpinnings   
Reference  Theoretical Model 
Venkatesh, Morris, Davis & Davis (2003)  
- Unified Theory of Acceptance and Use of Technology (UTAUT) 
Pratto, Sidanius, Stallworth & Malle (1994)  
- Social Dominance Theory 
Morgan & Hunt (1994)  
- Commitment-Trust Theory 
Dodds, Monroe & Grewal (1991)  
- Product Evaluation Model 
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2.4 Model and Hypotheses 
2.4.1 Dependent Variable 
Behavioural Intention (BI) denotes the intention of an individual to undertake a particular 
behaviour.  This is based on Ajzen’s Theory of Planned Behaviour (TPB) (Ajzen, 1991).   
Davis et al. (1989) references Ajzen (1991) when arguing that BI is a measure of the 
strength of an individual’s intention to perform a specific behaviour, and Bandura (2001) 
suggests that intentions focus on expected action.  These claims that intention can be used 
to measure action are corroborated by empirical studies suggesting that actual behaviour 
follows behavioural intention (Venkatesh et al., 2003; Davis et al., 1989).  By taking this 
view, the potential use of an e-prescribing system by physicians may be estimated by the 
measure of Behavioural Intention, even where actual use cannot be measured. 
 
Due to intention being the process of acting “mindfully to make desired things happen” 
(Bandura, 2001, pg. 5), it may be proposed that where behavioural intention exists, an 
active acceptance of that system exists too.  This view is supported by Ajzen (1991) who 
argues that intentions lead to actual behaviour.  Equally, BI is used to represent actual 
acceptance across multiple intention based studies (Holden & Karsh, 2009).  Thus for the 
purposes of this paper the behavioural intention variable will be the proxy for acceptance, 
and the dependent variable in the model. 
2.4.2 Independent Variables 
To what extent does the perceived change in performance from e-prescribing affect 
physicians’ intention to use an e-prescribing system? 
The independent variable Performance Expectancy (PE) denotes the perceived gains a 
user will achieve from using the system in their job context through direct improvement 
in work quality and quantity (Venkatesh et al., 2003).  These perceived gains are potential 
outcomes of using e-prescriptions, thus reflecting the attitude of the physician toward the 
outcomes (Ajzen & Fishbein, 1973)1.  PE is used interchangeably with perceived 
usefulness (PU) from TAM due to PE being derived from PU (Venkatesh et al., 2003; 
Holden & Karsh, 2009), but for the purposes of this study will be referred to as PE as per 
                                            
1
 Attitudinal considerations are based on expected outcomes while normative considerations refer 
to one’s perceived expectations of others (Ajzen & Fishbein, 1973). 
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the UTAUT model.  PE is relevant in the e-prescribing context due to empirical studies 
suggesting that e-prescribing will improve the performance of physicians by improving 
the quality of prescribing and dispensing, and lowering medication risks for patients  
(Kaushal et al., 2010; Tamblyn et al., 2006; Ammenwerth et al., 2008; Devine et al., 
2010; van Doormaal et al., 2009; Halamka et al., 2006; van der Sijs et al., 2006). 
 
PE is expected to have a positive relationship with BI (Venkatesh et al., 2003), due to 
physicians expected aim of achieving improved quality of medical care (Boonstra, 2003; 
Tamblyn et al., 2006; Wang et al., 2009; Pare et al., 2006).  Indications are that lessened 
call-backs and time savings on refills of prescriptions may improve the performance 
perception of the system by physicians (Tamblyn et al., 2006; Halamka et al., 2006), and 
the perceived indirect gains of their patients and subsequent pharmacists (Kaushal et al., 
2010; Ammenwerth et al., 2008; Devine et al., 2010; van Doormaal et al., 2009; Halamka 
et al., 2006; van der Sijs et al., 2006).  It thus follows that the degree of PE perceived by 
the physician may affect their intention to accept the system.  
 
H1:  Performance Expectancy will be positively related to Behavioural 
Intention. 
 
To what extent does the perceived usability of an e-prescribing system affect physicians’ 
intention to use such a system? 
To what extent does the perceived change in performance mediate the relationship 
between perceived usability and physicians’ intention to use the system? 
 
Effort Expectancy (EE) denotes the degree of ease, or degree to which the use is 
perceived to be free from physical or mental efforts, associated with using the system to 
get the desired results (Davis, 1989).  EE is sometimes used interchangeably with 
perceived ease of use from TAM (Holden & Karsh, 2009), but for the purposes of this 
study will be referred to as EE in order to maintain consistent variable names as presented 
by UTAUT (Venkatesh et al., 2003).  EE is relevant in the e-prescribing context where 
the introduction of a new system may increase the level of effort and time required of the 
physician, rather than diminish it (Eslami et al., 2007; Devine et al., 2010).  This 
increased level of effort and time may discourage physicians from using an e-prescribing 
system. 
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Studies have suggested that EE has a positive relationship with BI due to positive 
perceptions about the effort involved in using a new system (Venkatesh et al., 2003; 
Davis et al., 1989).   This is further supported in the e-prescribing context by empirical 
results (Boonstra, 2003; Tamblyn et al., 2006; Wang et al., 2009; Pare et al., 2006).  This 
suggests that the degree of EE perceived by the physician may affect the choice to accept 
the system. 
 
In earlier discussions within this study it was stated that there was empirical support for 
relationships between EE and PE (Davis, 1989; Venkatesh & Davis, 2000; Venkatesh & 
Bala, 2008).  Within the e-prescribing context this may be justified where difficulty in 
using the system may impede its usability, and thus its effectiveness.  Some studies raised 
concerns that using an online system took much longer than simply writing a script 
(Eslami et al., 2007; Devine et al., 2010), which would lower the expected improvements 
in job performance brought about by using e-prescriptions.  This study will thus extend 
UTAUT by including PE as a mediator between EE and BI. 
H2a:  Effort Expectancy will be positively related to Behavioural Intention. 
 
H2b:  Performance Expectancy will mediate the relationship between Effort 
Expectancy and Behavioural Intention 
 
To what extent does the degree to which a physician is socially influenced to use an e-
prescribing system affect the physician’s intention to use such a system? 
To what extent does the perceived change in performance mediate the relationship 
between social influence and physicians’ intention to use the system? 
 
Social Influence (SI) comprises social norms and social factors (Venkatesh et al., 2003; 
Holden & Karsh, 2009) and denotes the level to which the participant believes others, of 
perceived importance to the participant, believe the system should be used.  This 
precludes the physician’s personal attitude of the system, and focusses on the 
expectations of others (Ajzen & Fishbein, 1973).  This is relevant due to physicians 
perceiving that e-prescribing may affect their immediate social status, being influenced 
into the behaviour by other parties (Boonstra, 2003).  Furthermore there are indications 
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that the social makeup of the practice may affect physicians’ acceptance (Simon et al., 
2009; Fischer et al., 2007).   
 
Higher levels of SI are suggested to increase the intention to change behaviour, due to a 
feeling of social obligation to take part, or not take part, in that behaviour (Ajzen, 1991).  
It has been suggested that SI has no significant relationship with behavioural intention 
within voluntary settings (Venkatesh et al., 2003), but other studies do not support this 
view, and rather suggest that voluntariness has no effect on the relationship between SI 
and behavioural intention (Ajzen, 1991; Fischer et al., 2007).  Due to the lack of 
consensus, this study will test the relationship between SI and physicians’ intention to use 
an e-prescribing system in a voluntary setting. 
  
The original TAM excluded SI, partly due to psychometric problems, but it did 
acknowledge that further research should investigate the impact of social influence on 
usage behaviour (Davis et al., 1989).  One element of this is the effect on PE by SI, where 
SI may influence the user’s expectations of performance from the system, especially at 
the early adoption phase (Venkatesh & Davis, 2000; Venkatesh & Bala, 2008).   This 
proposed effect ties in with e-prescribing studies (eg Halamka et al., 2006) where the 
benefits of the systems were communicated through colleagues that the doctors would 
listen to. This study will extend UTAUT by including PE as a mediator between SI and 
BI. 
 
H3a:  Social Influence will be positively related to Behavioural Intention. 
 
H3b:  Performance Expectancy will mediate the relationship between Social 
Influence and Behavioural Intention 
 
To what extent does the degree to which a physician is social dominance orientated affect 
the physician’s intention to use an e-prescribing system? 
 
SI’s inclusion in UTAUT, as mentioned in hypothesis H3a, pertains to the positive 
influence on one’s behaviour brought upon by important others.  SI does not, however, 
take into account the possible negative influence, or individual’s reluctance to use a 
system, should those who are not part of the important others believe he or she should use 
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the system.  This phenomenon, where an individual is reluctant to use a system because 
certain others encourage the use of the system, is referred to as social dominance 
orientation or SDO.   
 
Individuals who are highly SDO rated may actively seek out corporate structures which 
tend to favour hierarchy-enhancing ideologies and policies (Pratto et al., 1994).  
Furthermore, these social dominance stereotypes are easily learned and activated by 
being within such hierarchy-enhancing social structures (Sidanius & Pratto, 1999).   
Given that the profession of physicians is generally considered to be a highly hierarchical 
and dominant profession (Freidson, 2007), it follows that physicians are susceptible to 
high levels of SDO. 
 
Sidanius & Pratto (1999) argue that individuals with high levels of SDO are more likely 
to resist changes to the status quo, such as those brought about through new systems, and 
Mittelstaedt, Grossbart, Curtis & Devere (1976) state that individuals with higher levels 
of social stereotypical views are less likely to adopt new innovations due to their “closed-
mindedness”.  The argument of lower adoption by high level SDO individuals is 
corroborated by suggestions of lower adoption rates amongst physicians of new quality 
improvement systems compared to other professions (Shekelle, 2002; Gollop et al., 2004; 
Davies et al., 2007).  Physicians have been shown to be less likely to take on new 
systems, especially when these systems are suggested by individuals from other 
professions (Gollop et al., 2004; Davies et al., 2007).  Thus it follows that intolerant 
views about changes brought about by the implementation of e-prescribing systems leads 
partly to the lower adoption of these e-prescribing systems. 
 
SDO thus extends the UTAUT model in the context of physicians’ intention to use e-
prescribing systems. 
 
H4:  Social Dominance Orientation will be negatively related to Behavioural 
Intention. 
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To what extent does the perceived price value of an e-prescribing system affect 
physicians’ intention to use such a system? 
 
UTAUT does not cater for the impact of the financial cost of a system on an individual’s 
intention to use the system.  Within the e-prescribing context it has been suggested that 
financial incentives should be introduced to encourage physicians to use e-prescriptions 
(Crosson et al., 2011).  This focus on the financial aspect is due to concerns that e-
prescribing systems are a hard sell because the physician generally has to bear the cost of 
this technology (Chin, 2003; Crosson et al., 2011).  In support of this concern, some 
studies have cited the cost of e-prescribing systems as a barrier to their use (Smith, 2006; 
Halamka et al., 2006). 
 
The impact of financial costs on the use of systems may be explained by the Product 
Evaluation Model proposed by Dodds et al. (1991), which suggests that a willingness to 
pay for a product is related to the perceived value of that product.  Perceived value is 
built from a combination of the perceived quality of the product, versus the perceived 
monetary cost of using the product (Dodds et al., 1991).  This suggests that a higher price 
for a product would lower the perceived value, and consequently lower the willingness or 
intention to buy and use.   Where physicians may be required to bear an element of the 
cost of a product, in this case an e-prescribing system, a lower perceived cost value of the 
system may cause a lower acceptance of the system, and thus a lower intention to use. 
 
The product evaluation model of Dodds et al. (1991) has been used in studies modelling 
acceptance where perceived value may lead to the acceptance of a product (Chu & Lu, 
2007).  This broad view of product value leading to acceptance took a general approach 
to perceptions of cost, without limiting it to direct monetary cost.  An example of this is 
where Chu & Lu (2007) described a low perceived ease of use as a potential cost 
detracting from the value of the system.  A more focussed approach, however, is taken by 
Venkatesh et al. (2012), where the perceived price value variable is restricted to monetary 
cost, in line with the original model of Dodds et al. (1991).  Venkatesh et al.’s (2012) 
study focused on the perceived value variable, rather than the factors leading to that 
perceived value variable.  This approach to price value enables the cost factor’s expected 
relationship with acceptance to be measured, without adding considerable complexity to 
the model (Venkatesh et al., 2012).   
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The variable of perceived price value is thus denoted by Price Value (PV) and represents 
the trade-off between perceived benefit of a system and its price (Venkatesh et al., 2012; 
Dodds et al., 1991).  Price Value extends the UTAUT model in this study, where price 
value is a factor of behavioural intention in the context of physicians’ intention to use e-
prescribing systems. 
 
H5:  Price Value will be positively related to Behavioural Intention. 
 
To what extent does the perceived change in performance mediate the relationship 
between confidence in the system’s reliability and physicians’ intention to use the 
system? 
 
UTAUT is further extended by Trust in technology, which denotes the willingness to 
depend on a trusted system (Gefen et al., 2003), where a lack of trust will deter one from 
entering into the transaction (Dasgupta, 2000).  This is relevant in the e-prescribing 
context due to the potential medical risks if the e-prescribing system should prove to be 
unreliable or faulty, such as displaying incorrect medication or patient information to 
physicians or pharmacists.  While the concept of low trust in e-prescribing has been 
discussed as a potential barrier to acceptance of e-prescribing systems (Smith, 2006; van 
der Sijs et al., 2006; Crosson et al., 2011) it has not been empirically tested with 
physicians.   
 
If a physician believes that an e-prescription system will not function in a way that 
warrants use, it is unlikely that the physician will use the system.  Gefen et al. (2003) 
demonstrated a relationship between trust in a system vendor and the subsequent 
acceptance of that system vendor’s technology, where the users had previous experience 
with the vendor of that technology.  In the current study there is no expected prior 
experience of the physicians with any particular related vendor, and thus the trust needs 
to be based on the perceived quality and reliability of the service, as is inferred by 
Morgan & Hunt (1994) and suggested by Garbarino & Johnson (1999).  This indicates 
that the physician’s trust would need to be placed in the expected performance of the 
system in the functionality that it is expected to provide.  Hence it follows that trust in the 
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system may to lead to an expectation of performance, and subsequently to an intention to 
use the system. 
H6:  Performance Expectancy will mediate the relationship between Trust and 
Behavioural Intention. 
 
The adapted model based on the hypotheses is shown in Figure 2.1.  
 
 
Figure 2.1 - Model of factors and their relationships with Intention, adapted from Venkatesh et al. (2003). 
 
2.4.3 Controls 
Additional controls for Age and Gender are included in this study.  The UTAUT model 
includes Age and Gender (Venkatesh et al., 2003), however these variables are given less 
emphasis in some studies (Holden & Karsh, 2009; Im et al., 2011).  Within the e-
prescribing context Wang et al. (2009) used the UTAUT model, but failed to find support 
for the effect of Age and Gender.  Consequently, Age and Gender are not used as 
moderators within the model, but will be used as control variables to ensure they have no 
material effect on the hypothesised relationships. 
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2.5 Chapter Summary  
This chapter reviewed existing literature in the context of adoption of e-prescribing 
systems by physicians.  Through this process, a research gap was identified, and a 
number of factors were proposed as determinants of physicians’ intention to adopt e-
prescribing systems. 
 
The following hypotheses were formed: 
• H1: Performance Expectancy will be positively related to Behavioural Intention. 
• H2a: Effort Expectancy will be positively related to Behavioural Intention. 
• H2b: Performance Expectancy will mediate the relationship between Effort 
Expectancy and Behavioural Intention. 
• H3a: Social Influence will be positively related to Behavioural Intention. 
• H3b: Performance Expectancy will mediate the relationship between Social 
Influence and Behavioural Intention. 
• H4: Social Dominance Orientation will be negatively related to Behavioural 
Intention. 
• H5: Price Value will be positively related to Behavioural Intention. 
• H6: Performance Expectancy will mediate the relationship between Trust and 
Behavioural Intention. 
The following chapter will build a data collection and analysis strategy to test these 
hypotheses. 
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CHAPTER 3:   RESEARCH METHODS 
3.1 Chapter Introduction 
This chapter describes the research method and tools used to collect data for the research 
into the factors supporting physicians’ Behavioural Intention (BI) to use e-prescribing.  
These factors are Performance Expectancy (PE), Effort Expectancy (EE), Social 
Influence (SI), Social Dominance orientation (SDO), Price Value (PV) and Trust.  The 
methods and tools selected are done so as to achieve valid and reliable results, 
generalisability of conclusions and repeatability of the research. 
3.2 Research Methodology 
Two main paradigms can generally be identified in existing information systems 
research, these being the positivist and interpretivist paradigms (Orlikowski & Baroudi, 
1991; Gregor, 2006).  Positivist studies typically test theory, generally making use of 
quantitative measures (Orlikowski & Baroudi, 1991), allowing reductionist, statistical 
analysis techniques such as regression analysis and correlation analysis to be conducted 
on the data (Punch, 2005; Bhattacherjee, 2012).  A limitation in this method may exist 
due to its isolationist approach, where variables not included in the survey may have been 
relevant, but were never measured (Bhattacherjee, 2012).  Interpretivist studies generally 
aim to understand the phenomena through evaluating the participants and the contextual 
setting of the study (Orlikowski & Baroudi, 1991).  Qualitative research typically lends 
itself to subjective interpretation of phenomena by evaluating participants within contexts 
(Punch, 2005).  The qualitative approach allows for a holistic view, where interpretations 
can be made on the meaning of the response based on language and context of the 
answers, but this also can allow for some limitations, such as observer bias 
(Bhattacherjee, 2012).   
 
The current study lends itself to a positivist, quantitative approach because it aims to test 
existing and modified models, rather than to build theory. The quantitative, numerical 
data collection method aims to empirically test the stated hypotheses in a manner which 
is repeatable, reliable and valid, and the results generalisable.  This method is selected in 
order to measure statistically significant relationships between the dependent variable BI 
and the relevant independent variables (PE, EE, SI, SDO, PV and Trust).  The 
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quantitative study makes use of an online survey, the results of which are measured 
numerically.  This method is able to suggest relationships between the relevant variables, 
in order to support the hypotheses, or fail to support the hypotheses.   
3.3 Research Design 
The survey is presented through an online survey (Appendix B) which is emailed to the 
respondents, along with a cover letter explaining the purpose of the survey (Appendix E).  
Surveys are useful when individual people are the unit of analysis (Bhattacherjee, 2012), 
such as the individual physicians of this study.  The online survey made use of the form 
function on Google Docs, a free, online document management and storage application.  
All items used the same 5-point Likert scale, ranging from ‘Strongly Disagree’ through to 
‘Strongly Agree’. 
3.3.1 Items Section 
The first two sections of the questionnaire are made up of the items discussed later in this 
chapter in Section 3.5.  These were separated into two sections for ease of understanding 
for the respondent, one pertaining to the respondent’s perceptions on the system, and the 
other pertaining to the respondent’s perceptions on people.  In order to avoid the negative 
impression of a large number of questions, new pages were used every 15 questions, or 
closest to 15 for logical flow.  The response headings (‘Strongly Disagree’ through to 
‘Strongly Agree’) were repeated on the same page where natural scrolling in the page 
may hide the original headings at the top of the page. 
 
It was not deemed necessary for any scales to have a ‘none’ or ‘not applicable’ option.  
This was because no scales were conditional to specific respondent categories, and it was 
expected that all scales would be applicable to all respondents. 
3.3.2 Demographics 
The third section of the questionnaire captures demographic data.  This is placed at the 
end of the survey after the respondent has committed their time to filling out the survey 
as these are seen to be less threatening (Bhattacherjee, 2012).  The respondent’s age and 
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gender are placed in this section.  These are based on Venkatesh et al. (2003), and are 
used to add richness to the study.  
3.3.3 Respondents’ Exposure to E-prescribing 
Respondents would need to have had some direct exposure or experience with the 
relevant systems to give meaningful responses (Fazio & Zanna, 1981).  Davis (1989) 
needed to ensure respondents’ familiarity with the system in his two initial studies when 
testing TAM. The first study simply asked respondents whether they have used the 
relevant system and excluded those who had not, and the second study allowed the 
respondents just one hour of training on the system before the surveys were distributed.  
In a similar approach for the initial UTAUT test, Venkatesh et al. (2003) delivered the 
surveys to the respondents as they completed the system training.  This approach around 
training sessions was not always possible with other acceptance and intention studies 
because the respondents were not within a controlled group in an organisation (e.g. 
Venkatesh et al., 2012; Bhattacherjee, 2001).  Instead, by using contact details from 
databases of existing system users, they could assume respondents had direct exposure to 
the systems in the respective surveys. 
 
In the current study the respondents were not part of a controlled training group.  
Consequently, a combination method of identification was used in order to ensure that the 
respondents had sufficient exposure to e-prescription systems.  All surveys included 
questions to establish the nature of the exposure that the respondent had had to e-
prescribing systems, similar to the method adopted by Davis (1989).  Where possible, 
respondent names were extracted from actual e-prescription system databases for the 
cover letter salutation, much as Bhattacherjee’s (2001) method. 
 
Due to the possibility that some of the respondents may have been using e-prescriptions 
for a few months, and the concern that the behavioural intention items may not be 
phrased correctly for respondents with extended exposure to e-prescribing, a preliminary 
test was done to check the tense of the questions.   This was done with a group of 
individuals in a private company who had started using a new risk system a few months 
prior.  Two sets of the same questions were provided, with different tenses, and then the 
respondents were asked whether one set made more or less sense than the other.  All 
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respondents felt that the tenses made no difference to their understanding of the 
questions.  As a result of this, the survey for this research could use one generic set of 
questions for all respondents. 
3.4 Population and Sample 
The study is directed at practicing physicians who have had exposure to e-prescribing 
systems.  The sample group was collected from two sources.  The first source was from a 
database of an e-prescribing application provider, Health-Soft.  The data provider granted 
permission (Appendix C) after having sight of the survey questionnaire, and on condition 
of ethical clearance from the University’s ethics committee.  This provider had 421 email 
addresses of physicians who had had exposure to their e-prescribing system, although not 
all the physicians on the list were actively using the system.  Of the 421 entries on this 
list, 379 were valid email addresses.  The cover letter sent to these respondents included 
the Health-Soft logo, as requested by the provider (Appendix E).   
 
The second list was extracted programmatically from the South African Yellow Pages, a 
free online contact directory.  This list held details of over ten thousand physicians, but 
only 260 of these entries had email addresses.  Cover letters sent to these potential 
respondents did not include Health-Soft’s logo. 
 
Due to the generic set of questions mentioned above, and the conditional questions 
confirming the respondent’s exposure to e-prescribing, the data set from the Health-Soft 
could be joined with the data set from the South African Yellow Pages into one sample 
group.  The nature of the sample, comprising individual physicians who are not instructed 
to use e-prescription systems, indicates that the study is conducted in a voluntary setting. 
 
This provided a combined sample of 639 potential respondents. 
3.5 Instrument Construction 
The survey made use of standardised 5 point Likert scales for respondents to mark their 
perceptions related to the specific question.  Content validity of the items is based on 
previous use and validation of the items, ensuring they fully represent the relevant 
variables.  Where applicable, items were adjusted to the context of e-prescribing, and the 
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tenses of questions were changed to be aligned to one another.  All questions related to an 
e-prescribing system were generalised to ‘e-prescribing system’ rather than a specific 
system’s name.  This is to allow for an understanding of the technological concept itself, 
rather than a system developed by a particular provider.  This generalised naming 
approach has previously been used with UTUAT (Venkatesh et al., 2012).   
3.5.1 Behavioural Intention 
The items operationalising this variable aim to measure the respondent’s intention to use 
an e-prescription system, and are based on the items used by Venkatesh et al. (2003).  
These items are: I intend to use e-prescriptions, given the opportunity; I predict I would 
use e-prescriptions, given the opportunity; I plan to use e-prescriptions, given the 
opportunity. 
3.5.2 Performance Expectancy 
H1:  Performance Expectancy will be positively related to Behavioural Intention. 
The items representing this variable aim to measure the respondent’s expectation of 
improved work performance resulting from the use of an e-prescribing system.  These 
items are based on the study done by Davis (1989).  The UTAUT items of PE from 
Venkatesh et al. (2003) were not used in this study due to UTAUT’s inclusion of some 
items pertaining to salary benefits which were not relevant to this study.  Due to the 
similarities between PE and Perceived Usefulness (Venkatesh et al., 2003; Holden & 
Karsh, 2009), mentioned earlier in this study, the items were used interchangeably.  
These include: Using e-prescriptions in my job would enable me to accomplish tasks 
more quickly; Using e-prescriptions would improve my job performance; Using e-
prescriptions would enhance my effectiveness on the job. 
3.5.3 Effort Expectancy 
H2a:  Effort Expectancy will be positively related to Behavioural Intention. 
 
H2b:  Performance Expectancy will mediate the relationship between Effort Expectancy 
and Behavioural Intention. 
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The variable representing the respondent’s expected effort to learn the system was 
operationalised through items based on Davis (1989).  Due to the similarities between EE 
from UTAUT and Perceived Ease of Use from TAM (Venkatesh et al., 2003; Holden & 
Karsh, 2009), the items were used interchangeably.  Davis (1989) had a greater number 
of validated items than UTAUT, and as a result those items were selected in preference to 
those of UTAUT.  The items include: Learning to operate e-prescriptions would be easy 
for me; I would understand how to interact with e-prescriptions; I would find e-
prescriptions easy to use. 
3.5.4 Social Influence 
H3a:  Social Influence will be positively related to Behavioural Intention. 
 
H3b:  Performance Expectancy will mediate the relationship between Social Influence 
and Behavioural Intention 
The items used to operationalise Social Influence are adapted from Ajzen’s (1991) 
subjective norms items.  The full list of items of SI from Venkatesh et al. (2003) were not 
used due to some items being relevant only in larger organisations, which would appear 
irrelevant in small medical practices.  Ajzen (1991) makes only two items available, so in 
order to increase the number of items operationalising the SI variable for improved 
reliability, an extra item presented by Yi, Jackson, Park & Probst (2006) was included.  
Thus the items for SI are: People who influence my behaviour think that I should use e-
prescriptions; People who are important to me think that I should use e-prescriptions; 
People whose opinions I value think I should use e-prescriptions. 
3.5.5 Social Dominance Orientation 
H4:  Social Dominance Orientation will be negatively related to Behavioural Intention. 
This variable’s items aim to measure the respondent’s social dominance orientation level.  
The items selected for this study are based on Pratto et al. (1994).  Commonly there are 
16 items used to measure SDO, which, for the purposes of this study were considered too 
onerous for a respondent to fill out, so the item count was reduced to a manageable four 
for questionnaire purposes.  The source study did not supply sufficient information to 
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identify the four highest loading items (Pratto et al., 1994).  A recent study made use of 
the same SDO items (Ho et al., 2012), which allowed easier access to the current authors, 
to obtain the factor loadings of the 16 SDO items, and thus allow the items in this study 
to be limited to the top four loading items.  Email correspondence with the author of the 
recent study (Ho, 2012, pers. comm. 6 June) confirmed the four top loading items, which 
were used in this study.  These include: It's probably a good thing that certain staff are at 
the top and others are at the bottom; If certain categories of staff stayed in their place, we 
would have fewer problems.  
3.5.6 Price Value 
H5:  Price Value will be positively related to Behavioural Intention. 
This variable’s items aim to measure the respondent’s perception of the monetary cost of 
using the system, compared to the perceived value of using the system.  The PV items 
used in this study are based on Venkatesh et al. (2012), and are adapted to the e-
prescribing context.  They include: e-Prescriptions are reasonably priced; e-Prescriptions 
is good value for money. 
3.5.7 Trust 
H6:  Performance Expectancy will mediate the relationship between Trust and 
Behavioural Intention. 
The items used to measure the respondent’s trust in the system were based upon the items 
from Garbarino & Johnson’s (1999) study.  After adjustment for the e-prescribing 
context, the items included: I believe e-prescriptions can be counted on to fulfil their 
function well; I believe e-prescriptions will be reliable; I believe e-prescriptions cannot 
always be trusted. 
One item under Trust, I believe e-prescriptions cannot always be trusted, was reverse 
coded in the source text.  Some deliberation was made toward changing this question into 
a standard coding for ease of reading.  The proposed item ran as such: “I believe e-
prescriptions can always be trusted”, but this wording appeared to the researcher to have 
little face validity.  As a result, the item was kept as a reverse coded question. 
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A full list of item numbers, items and sources is available in Appendix A, and the final 
survey is available in Appendix B.  
3.6 Permission, Ethical Considerations and Delivery 
Prior to any questionnaires being sent to potential respondents, ethical clearance was 
unconditionally approved by the sponsoring University with protocol number 
CINFO/1021 (Appendix D).  Permission to use the data from Health-Soft was agreed 
(Appendix C) after a lengthy process to meet their requirements.  One of these was to 
include their logo on emails sent to respondents from their list.  The list taken from the 
Yellow Pages, however, is in the public domain, and no explicit permission was 
requested.    
The potential participants would be invited to take part in the survey via a cover letter 
(Appendix E), without any obligation being placed upon them to do so, and without any 
monetary reward should they choose to respond to the survey.  Contact details were made 
available for them to put their questions forward if they had any queries relating to the 
survey or the study.  Participants remain anonymous because no personal identification 
information will be stored, and any published results are reported in aggregated form.   
3.7 Pre-Test 
Senior researchers assisted with a pre-test on the survey.  This sample of researchers were 
selected and contacted from Information Systems and Economic Sciences disciplines 
from the sponsoring university.  Once willingness to assist was received from the 
researcher, the pre-test was forwarded to them in the same format as it would be to 
respondents.  Of the sample of senior researchers, four pre-tests responses were received. 
A number of grammatical errors in the cover letter and questionnaire were identified and 
corrected through this process.  Further to these changes were alterations to the question 
order, with the dependent variable placed at the end of section 1 of the survey. 
The pre-test also raised concerns around the SDO questions, which were considered to be 
of a sensitive nature regarding perceptions or stigma of other groups of people.  An 
example of this was the phrase ‘inferior groups’, which may have implied that the 
respondent was obliged to believe that inferior groups existed.  This SDO item was 
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tempered to be more neutral by using the phrase ‘certain groups’ instead of ‘inferior 
groups’. 
3.8 Pilots 
An initial pilot study was conducted by selecting a random sample from the list of 
potential respondents.  This random approach was achieved by selecting one potential 
respondent from every 20 to 30 row items on the list.  These were marked so they would 
not be picked up in future iterations.  This first pilot had 12 in the group, and despite 
follow up emails, a low response rate of 25% was returned, with only two of those 
responses being fully completed from this pilot, lowering the effective response rate 
down to 16%. 
The low response rate was raised as a concern for the main study, as the potential sample 
group indicated that a response rate in the region of 20% may be required for sufficient 
statistical testing.  A number of strategies were devised in order to improve the response 
rate, which were tested in two further pilot studies.  These extra pilot groups were 
selected using the same method as the initial pilot. 
The second pilot study involved personal phone calls to 8 potential respondents prior to 
the email being sent to them.  This allowed the researcher to introduce himself personally 
to the potential respondent, and explain the purpose of the study.  This approach was very 
onerous and achieved only limited success.  It took up to four phone calls per respondent 
to get hold of the relevant person, sometimes while they were resting at home, and still 
returned a low response rate.  Due to the poor results obtained this onerous approach was 
abandoned. 
The final pilot study combined a personalised salutation and an update to the cover letter 
emphasising that the study was for degree purposes rather than commercial purposes.  
This pilot study sent emails to 15 potential respondents.  After follow up emails, this pilot 
had an improved response rate of 20%, and the responses from the pilot were usable for 
the main study, as no further changes were required. 
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3.9 Main Data Collection 
After the pilot tests, 599 valid email addresses of potential respondents remained.  Given 
the smaller size of the list of potential respondents, the emails were sent to every valid 
email address on the list which remained after the pilots.  Some of the email addresses 
were indicative of a receptionist or administrative role, but during the pilots it was found 
through some responses that the admin staff would forward the email on to their 
physician.  Follow up emails were sent twice before the cut-off date, and these follow up 
mails also suggested passing the survey onto other potential respondents if possible. 
 
Based on the response rate from the final pilot test, it was expected that a response rate of 
between 15 to 20% would be achieved during the main data collection, putting the 
response count at approximately 100.  
3.10 Data Analysis 
3.10.1 Reliability, Validity and Consistency 
The data will be cleansed of incomplete or outlying responses, and any responses from 
mandatory settings will be excluded. Convergent validity will be confirmed through 
principal component factor analysis, conducted across the item groups using varimax 
rotation, expecting a minimum loading of .60.  This method has been used with UTAUT 
(Im et al., 2011) and with technology acceptance (Gefen et al., 2003).  Statistical validity 
and reliability of variables will be checked using a Cronbach Alpha test, with an alpha 
level expected above 0.70.  Individual items may need to be removed from groups should 
the alpha result be too low.  Composite variables will be created from the grouped items, 
and skewness and kurtosis will be checked on these, with acceptable ranges being within 
-3 and +3 (Hair, Babin, Money & Samouel, 2007).   
3.10.2 Individual Relationships 
Correlation analysis will be conducted in order to do preliminary relationship tests 
between variables.  P values below 0.05 will be used to measure statistical significance of 
the relationships between variables (Hair et al., 2007).  This method is used as a 
preliminary test to identify relationships between two variables in isolation, without the 
effects of other variables in the model, for initial partial support of hypotheses.  It also 
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serves as a precursor for the mediator tests, where correlation between PE and EE, SI or 
Trust may begin to indicate the meditating effect of PE (Baron & Kenny, 1986). 
 
The correlation analysis results will be checked for any bias caused by the control 
variables of Age and Gender.  This is done to check whether the control variables have 
any influence on the relationships between the other variables (Hair et al., 2007).  The 
test will look for any material change in the correlation analysis results when Age and 
Gender are controlled for.  An absence of any material change in the results may suggest 
that the control variables could have no influence on the correlation in question (Hair et 
al., 2007).   
3.10.3 Model Tests 
Multicollinearity tests will be conducted on the variables to confirm that there are no 
independent variables which are too highly correlated.  The Variance Inflation Factor 
(VIF) value is to be below 5.0 and the minimum tolerance is 0.10, (Hair et al., 2007).   
 
Multiple-regression will be used on the centralised variables for testing hypotheses H1 to 
H6, expecting correlation between the dependent variable BI and the independent 
variables PE (H1), EE (H2a), SI (H3a), SDO (H4) and PV (H5).  Significance will be 
checked against the p < 0.05 level.   
 
In order to test the mediating effect of PE on the relationship between BI and EE (H2b), 
SI (H2b) and Trust (H6), the steps laid out by Baron & Kenny (1986) will be followed.  
These steps are (1) to confirm regression between the mediator (PE) onto the mediated 
independent variables (EE, SI and Trust); (2) to run regression analysis between the 
dependent variable (BI) and the mediated variables, and then (3) to run regression 
analysis between the dependent variable and the other individual variables.  If the first 
two tests have statistical significance, and the 3rd test has statistical significance for the 
mediator and dependent, and no statistical significance for the independent and 
dependent, then the mediated relationship will be supported. 
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3.11 Constraints 
The broad reach of potential respondents across South Africa may improve the 
generalisability of the study, as site specific factors may play less of a role in the results.  
However, with the respondents requiring access to email and the Internet, and being 
advertised on the Yellow Pages or linked through one software provider, certain sample 
representative limitations may creep in.  It is likely that any physician who does not have 
an email account, or whose contact details are not on the Yellow Pages or is linked to 
another e-prescribing provider, will not be contacted via the survey, causing sample bias.  
Equally those who are the listed physician on any database may be a central contact in the 
practice, potentially omitting junior physicians in a practice not listed.  This is partially 
addressed by follow up emails to inform the reader that the survey may be passed onto 
others to whom the survey may be relevant. 
 
The study may encounter bias where physicians who are against the idea may choose not 
to respond, whereas those who are more open to the idea make up the bulk of the 
responses, who in turn may attempt to answer in such a way to promote their views.  This 
limitation may be minimised to a degree by follow up emails to coax responses from a 
full range of potential responders. 
 
The questionnaire contains all variables in the research, being captured by the same 
person at the same time, which may create a common method bias.  This bias may be 
limited by conducting the Harman’s one-factor test as described by Podsakoff & Organ 
(1986). 
3.12 Chapter Summary 
This chapter describes the tools and methods used to gather and analyse the items in order 
to measure the variables and test the model.   
The items are adapted from previous studies (see Table 3.1), and they will be delivered to 
potential respondents through an online survey which will be emailed to them.  The 
responses will be validated and tested against the model to test the various hypotheses.   
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  Table 3.1: Summary of items 

Variable Items Source 
Behavioral intention Venkatesh et al. (2003) 
Performance Expectancy Davis (1989) 
Effort Expectancy Davis (1989) 
Social Influence Ajzen (1991) with extra item from Yi et al. (2006) 
Level of Social Dominance Orientation Pratto et al. (1994), with factor analysis from Ho et al. (2012) 
Trust Garbarino & Johnson (1999) 
Price Value Venkatesh et al. (2012) 
 
The next chapter will describe the data results of the survey, and the analysis thereof. 
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CHAPTER 4:   DATA ANALYSIS 
4.1 Chapter Introduction 
This chapter reports the statistical analysis process and results of the data collected to test 
the hypotheses.  These hypotheses consider the relationships between Performance 
Expectancy (PE), Effort Expectancy (EE), Social Influence (SI), Social Dominance 
orientation (SDO), Price Value (PV) and Trust, and the Behavioural Intention (BI) to use 
e-prescribing. 
 
The characteristics of the sample are described, after which reliability and validity tests 
are conducted on the variables for further analysis.  This analysis comprises descriptive 
results such as mean and standard deviation of the variables.  To test the hypotheses, 
correlation and multiple regression analysis are performed to measure the strength of the 
relationships. 
4.2 Sample Profile and Screening 
4.2.1 Data Preparation 
The final pilot study and the main study combined to create a list of 614 potential 
respondents.  These resulted in a total of 78 responses, which equates to a response rate 
of 12.7%.  This response rate was lower than expected based on the final pilot study 
conducted which returned a response rate of close to 20%, however it did closely match 
the response rates of the initial pilot studies.  The responses were coded into Microsoft 
Excel by using a value of 1 for Strongly Disagree, through to 5 for Strongly Agree.  The 
converted data was then imported into SPSS (version 17.0.1).  Five responses which had 
more than 3 questions incomplete were identified as false captures and were manually 
removed, leaving 73 responses for further analysis. 
4.2.2 Frequency Distributions 
Prior to data screening and setting of missing values, a frequency distribution was done 
on the items.  This frequency table is available in Appendix F.  This indicated high 
frequencies of Agree and Strongly Agree for Behavioural Intention items, Performance 
Expectancy items and Effort Expectancy items.   This suggests that, in general, most of 
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the respondents had a higher level of agreement toward their intention to use e-
prescribing systems, and that they believed the system would improve their work 
performance, and require little effort to use the system.  The clustering of these results 
may result in frequency symmetry problems, such as distribution skewness. 
4.2.3 Reverse Coded Items 
The single reverse coded item (T4: “I believe e-prescriptions cannot always be trusted”) 
was reversed to align its scale with the rest of the items.  This required changing the 
responses of this item in a structured manner, without falsifying any responses.  
Responses of 1 were changed to 5; responses of 2 were changed to 4; responses of 4 were 
changed to 2 and responses of 5 were changed to 1.  This was achieved on the data set by 
subtracting 6 from each value, and multiplying the result by -1.  This effectively switched 
the coding of a variable’s values in line with the other variables in the study which use 5 
point Likert scales. 
4.2.4 Missing Values 
Across the 73 responses, and 29 individual items, there were 12 missing values, with no 
response having more than 3 missing responses.  These missing values were set to the 
series mean.  This process provides missing values with replacement values which are 
similar to the others in the series.  This prevents incomplete data sets from affecting the 
results. (Hair, Celsi, Money, Samouel & Page, 2011).   
4.2.5 Outliers 
Z-score, or standard score, analysis was conducted using the univariate method on the 
responses to determine the normality of the distribution of the data in a variable.  The z-
score value counts the number of standard deviations away from the mean value in the 
variable (Hair et al., 2011).  Based on the z-scores, one additional response was removed, 
because three values of that response were below -3.0.   
 
This left 72 responses (n=72) for further analysis.   
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4.2.6 Characteristics of Respondents: Current Use 
A higher percentage of the respondents are current users of e-prescriptions than those 
who are not currently using e-prescriptions.  Over 60% of respondents in this study 
indicated that they are currently using e-prescribing systems.  This higher percentage is 
not unexpected due to the sample being taken largely from a database of an e-prescribing 
system provider, which could suggest that most of those respondents are current users.  
The full details of current use can be viewed in Table 4.1.   
 
  Table 4.1: Characteristics of respondents: Current Use  
      Number Percentage  (%) 
     
 
Currently using e-Prescriptions 
   
 
Yes 
 
45 62.5 
 
No 
 
25 34.7 
 
Not stated 
 
2 2.8 
 
Total 
 
72 100.0 
Note  - 'Not stated' indicates responses where the relevant questions were not completed 
 
4.2.7 Characteristics of Respondents: Gender 
The majority of responses were obtained from male respondents, with only 21% coming 
from female respondents (see Table 4.2).  This skewed ratio between genders in this 
study is not unexpected, as the percentage of female physicians in South Africa has 
ranged between 25% and 30% in recent years (Breier, 2008).  The difference between 
genders in their intention to use e-prescribing is negligible.  This could indicate that 
gender plays little direct role in the use of e-prescribing.  4.2% of the responses did not 
indicate their gender, which made it impossible to infer anything from them related to 
gender.  The responses which had not indicated a gender will still be included in the 
hypotheses testing due to gender relationships not being tested as part of the model. 
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  Table 4.2: Characteristics of respondents: Gender 
        
      
Number 
of 
responses 
Percentage  
(%) 
Intention 
to use 
     
 
Gender 
   

Female 

15 20.8 4.07 

Male 

54 75.0 4.20 

Not stated 

3 4.2 2.45 

Total 

72 100.0 

Note  - 'Intention to use' represents the mean of the relevant group, 1 = low and 5 = high 
  
 - 'Not stated' indicates responses where the relevant questions were not completed 
 
4.2.8 Characteristics of Respondents: Age 
The time required to become a medical doctor in South Africa is six of years study, two 
years internship and a year of community practice (UCT, 2013).  This means that an 
average school leaver, who is 18 years old, going on 19, would have to be 27 years old, 
going on 28, before they can begin practicing medicine, presuming no specialisation.  
This may explain why no responses were attained from respondents below 30 (see Table 
4.3), as 9 years of preparation might leave very little time for a newly practicing doctor to 
be in the position to be making decisions about e-prescription systems.  Table 4.3 
indicates that, above the age of 30, respondents were from a variety of age groups.  The 
majority of respondents were between the ages 45 to 59, which may be the age that most 
physicians’ have established practices, and thus are in a position to be investigating e-
prescribing systems.  The group of respondents who are over the age of 70 is the only 
group with a low intention to use, perhaps because they are close to retirement and that 
they do not wish to change the way they do things. 
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  Table 4.3: Characteristics of respondents: Age 
        
      
Number 
of 
responses 
Percentage  
(%) 
Intention 
to use 
     
 
Age 
   

Below 30 years 

0 0.0 - 

30-34 

4 5.6 3.59 

35-39 

6 8.3 4.11 

40-44 

7 9.7 4.00 

45-49 

11 15.3 3.93 

50-54 

15 20.8 4.51 

55-59 

12 16.7 4.30 

60-64 

8 11.1 4.04 

65-69 

2 2.8 4.50 

70 years and over 

7 9.7 2.76 

Not stated 

0 0.0 - 

Total 

72 100.0 

Note  - 'Intention to use' represents the mean of the relevant group, 1 = low and 5 = high 
  
 - 'Not stated' indicates responses where the relevant questions were not completed 
 
4.2.9 Characteristics of Respondents: Cross Tabulation of Gender and Age 
Breier (2008) indicates that while the overall percentage of female physicians in South 
Africa has been between 25% and 30% in recent years, there has been a recent increase in 
the percentage of female graduate doctors.  Breier’s (2008) assertion of recent change in 
percentage of female physicians is partially supported by viewing Table 4.4 in this 
current study.  Table 4.4 shows a crosstab of Age and Gender which demonstrates that at 
the lower ages (or rather the most recent graduates) there are more Females than Males 
responding, and at the higher ages there are more Males than Females responding.   
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  Table 4.4: Characteristics of respondents: Cross-tabulation 
 Age Male Female Percentage of Women 

    
 
Below 30 years 0 0 - 
 
30-34 1 3 75% 
 
35-39 2 3 60% 
 
40-44 5 2 29% 
 
45-49 9 2 18% 
 
50-54 13 1 7% 
 
55-59 10 2 16% 
 
60-64 7 2 22% 

65-69 2 0 0% 

70 years and over 5 0 0% 

Total 54 15 22% 

 
   
Note  - Responses with no gender submitted were omitted from this table 
 
4.2.10 Characteristics of Respondents: Source of e-Prescribing System Knowledge 
When asked how they came to know of e-prescribing, the majority of respondents had 
found an e-prescribing system through their own research (see Table 4.5).  Interestingly, 
those who had heard about e-prescribing through a fellow medical professional were the 
ones with the highest intentions to use e-prescribing. This may be indicative of some 
social influence playing a role in their intention, where the in-group legitimacy of fellow 
colleagues may have a positive influence on a physician’s intention to use e-prescribing 
systems.   
  Table 4.5: Characteristics of respondents: Source of e-Prescribing 
knowledge   
      
Number 
of 
responses 
Percentage  
(%) 
Intention 
to use 
     
 
How did you hear about e-prescribing 
   

Personal research 

35 48.6 3.97 

Someone who is a medical professional 

20 27.8 4.32 

Someone who isn’t a medical professional 

16 22.2 3.8 

Not stated 

1 1.4 4 

Total 

72 100.0 

Note  - 'Intention to use' represents the mean of the relevant group, 1 = low and 5 = high 
  
 - 'Not stated' indicates responses where the relevant questions were not completed 
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The group who had heard of e-prescribing through non-medical professionals had the 
lowest intention to use, which may be linked to SDO levels in physicians.  These 
descriptive results should however be viewed with caution due to the lower response rate.   
4.3 Psychometric Properties 
4.3.1 Common Method Variance 
Common method variance is explained by Podsakoff & Organ (1986) as the problematic 
result of two or more variables’ measures being collected from the same source, where 
any defect in the source contaminates both, or all, measures.  In this study all the 
measures are taken from one source, being physicians, so it is open to the problems 
associated with common method variance.  Harman’s one-factor test, as described by 
Podsakoff & Organ (1986), makes use of an unrotated factor analysis, and should only 
one factor emerge, it is considered likely that the data suffers from common method 
variance.  In this study, the unrotated factor analysis produced 6 separate factors, which 
may suggest that this study is not overly affected by common method variance. 
4.3.2 Principal Component Factor Analysis 
Hair et al. (2011) describe factors as linear combinations of original variables.  Factors 
are used to explain as much as possible of the variance in the data by a few components 
(Hair et al., 2011).  These factors are derived by making use of Principal Component 
Factor Analysis (PCFA), in this case using the varimax rotation, which is the most widely 
used (Hair et al., 2011), with loadings below 0.60 being suppressed (Hair et al., 2007).  
The PCFA results can be seen in Table 4.6. 
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  Table 4.6: Results of Principal Component Factor Analysis 
  
Performance 
Expectancy 
(PE) 
Social 
Dominance 
Orientation 
(SDO) 
Social 
Influence 
(SI) 
Effort 
Expectancy 
(EE) 
Price 
Value 
(PV) Trust 
SDO1 
 
0.78 
    
SDO2 
 
0.936 
    
SDO3 
 
0.925 
    
SDO4 
 
0.913 
    
PE1 0.786 
     
PE2 0.856 
     
PE3 0.889 
     
PE4 0.912 
     
PE5 0.889 
     
PE6 0.807 
     
EE1 
   
0.627 
  
EE2 
   
0.813 
  
EE3 
   
0.835 
  
EE4 
   
0.86 
  
T1 
     
0.664 
T2 
     
0.734 
T3 
     
0.783 
SI1 
  
0.959 
   
SI2 
  
0.947 
   
SI3 
  
0.931 
   
PV1 
    
0.91 
 
PV2 
    
0.93 
 
PV3 
    
0.905 
 
Cronbach Alpha 0.96 0.92 0.97 0.87 0.97 0.88 
 
Three items had to be removed in order to have clean factor loadings above 0.60.  These 
are EE4: “I would find e-prescriptions to be flexible”; EE6: “I would find e-prescriptions 
easy to use” and T4: “I believe e-prescriptions cannot always be trusted”.  The question 
for T4 had been reverse coded, and was raised as a potential problem prior to the survey, 
but the decision was made to keep it in the original form as taken from Garbarino & 
Johnson’s (1999).  The results from the factor loadings suggest that the item did not load 
well with the others, which was not unexpected due to its reverse coding.  The dropped 
items are listed in Table 4.7. 
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  Table 4.7: Excluded items 
  
Construct 
Retained 
Items Item Number Item Question 
Effort Expectancy (EE) 4 
 
EE4 I would find e-prescriptions to be flexible 
EE6 I would find e-prescriptions easy to use 
 
Trust 3  T4 I believe e-prescriptions cannot always be trusted 
 
4.3.3 Internal Consistency and Reliability 
Internal consistency was checked across the resultant factors using Cronbach’s alpha test.  
Cronbach’s alpha, or coefficient alpha, returns a value between 0 and 1, with researchers 
generally looking for a minimum value of 0.70 (Hair et al., 2007).  The following alpha 
values were found for the independent variables: SDO: 0.917; PE: 0.964; EE: 0.870; 
Trust: 0.879; SI: 0.974 and PV: 0.966.  The dependent variable BI had an alpha value of: 
0.971.  Based on these values the internal consistency of the variables was considered to 
be very good.  The alpha values are available in both Table 4.6 and Table 4.8. 
4.3.4 Composite Variables 
After the internal consistency tests, the relevant scales were aggregated into composite 
variables by taking the average across each group of scales.  Further analysis would be 
done on the composite variables rather than the individual items.   
4.3.5 Descriptive Statistics (Composite Variables) 
All the variables had five possible values, ranging from 1 (Strongly Disagree) to 5 
(Strongly Agree).  The composite variables’ means ranged between 2.85 and 4.03.  SI 
was the only variable which had a mean below the median of 3, and BI and EE were the 
only variables with means above 4.  Based on the value of BI, one may deduce that most 
of the respondents had an intention to use e-prescribing.   
The mean of SDO was 3.1, and the mode response was 3.0.  The standard deviation of 
SDO was 0.93, which indicates the SDO responses were not very dispersed, suggesting 
that most SDO responses were around the neutral of 3.0.  One may conclude from this 
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that, on average, physicians who responded were either neutral in SDO, or chose to give 
the impression that they are neutral in SDO. 
The standard deviation of most of the variables was less than 1.0, except for SI which had 
the highest standard deviation at 1.06.  This demonstrates that the variables were not very 
dispersed about their means, which is indicative of consistency of responses (Hair et al., 
2011).  The means and standard deviations of all the variables are available in Table 4.8. 
  Table 4.8:  Composite variable reliabilities, validities and descriptive statistics 
  Variable Number of items Mean 
Standard 
Deviation 
Cronbach 
Alpha 
Minimum 
Factor 
loading 
Skewness Kurtosis 
    
  Behavioural Intention 3 4.03 0.99 0.97 0.97 -1.26 1.49 
  Performance Expectancy 6 3.86 0.98 0.96 0.79 -0.98 0.89 
  Effort Expectancy 4 4.01 0.71 0.87 0.63 -0.34 -0.39 
  Social Influence 3 2.85 1.06 0.97 0.93 0.06 -0.53 
  Level of Social Dominance Orientation 4 3.10 0.93 0.92 0.78 -0.14 0.04 
  Trust 4 3.57 0.88 0.88 0.66 -0.41 0.33 
  Price Value 3 3.46 0.89 0.97 0.91 -0.28 0.48 
    
Note - Factor loading for Behavioural Intention based on isolated analysis 

  
    
4.3.6 Skewness and Kurtosis 
Skewness checks are done to test for distribution symmetry (Hair et al., 2007; Hair et al., 
2011).   The checks on the composite variables indicated that all were well within the 
acceptable range of -3.0 and +3.0.  SI had the smallest absolute skewness value of 0.06.  
These skewness values indicate that the distribution of the data is reasonably symmetrical 
Hair et al. (2011) describe kurtosis as the measure of peakedness or flatness of a 
variable’s distribution.  Kurtosis values for this study were within the acceptable range of 
-3.0 and +3.0.  SDO had the smallest absolute kurtosis value, being 0.04. 
Based on these skewness and kurtosis values, the composite variables may be considered 
to have normal, symmetrical distributions.  The full results are available in Table 4.8. 
4.4 Correlation Analysis 
A correlation analysis was conducted across all variables as a preliminary test prior to the 
model test (see Table 4.9).  Apart from SDO, all independent variables had statistically 
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significant correlations with the dependent variable BI.  PE had the strongest correlation 
of 0.788 (p<0.001) with BI, and SI had the lowest correlation with PE of 0.317 (p<0.01).   
SDO had no significant relationships with any of the variables, and is excluded from 
further correlation analysis. 
Excluding SDO, all of the independent variables had significant correlations with at least 
two of the other independent variables, which may support further mediation testing.  PE 
had a significant correlation with all of the other independent variables, the strongest 
being Trust, at 0.676 (p<0.001).  SI had no significant correlation with EE, PV or Trust, 
with its strongest significant correlation being with PE, with 0.361 (p<0.001).  The 
correlation matrix is available in Table 4.9.  
The correlation analysis results were checked for influence from Age and Gender by 
observing whether there was any material change in correlation between two measured 
variables when the effect of Age or Gender is controlled (Hair et al., 2007).  When the 
effect of Age and Gender were controlled, there was no material change to the 
significance or correlation values between the relationships measured in the main 
correlation analysis.  This indicates that Age and Gender may have no influence on these 
relationships. 
 
  
  Table 4.9: Correlation matrix  
  
  Variable 1 2 3 4 5 6 7 
   1 Behavioural Intention 1 
     
2 Performance Expectancy 0.788*** 1 
    
3 Effort Expectancy 0.347** 0.521*** 1 
   
4 Level of Social Dominance Orientation 0.021 -0.060 0.071 1 
  
5 Trust 0.539*** 0.676*** 0.520*** 0.171 1 
 
6 Social Influence 0.317** 0.361** 0.015 -0.128 0.224 1 

7 Price Value 0.442*** 0.410*** 0.386** 0.045 0.479*** 0.199 1 
  
  
     * Correlation significant to the p < 0.05 level     
        
     ** Correlation significant to the p < 0.01 level 
 
  
     *** Correlation significant to the p < 0.001 level   
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4.5 Model Analysis 
Multiple regression analysis was used to test the proposed model.  As a precursor to 
multiple regression analysis, a number of tests are run on the data to ensure it will support 
multiple regression assumptions (Hair et al., 2007).   
4.5.1 Normality 
The normality test makes use of a probability plot (p-plot), checking for the observed 
standardised residuals against the expected standardised residuals.  To the eye, the 
observed residuals should cluster along the 45° line (Hair et al., 2007).  The p-plots for 
the variables in this study are available in Appendices G1 to G7, and these demonstrate 
sufficient normality in the data. 
4.5.2 Linearity and Homoscedasticity 
Scatter plots enable one to look for linearity and homoscedasticity to indicate that the 
distribution of the variables will support regression analysis (Hair et al., 2007).  This is a 
visual test, looking for both similarity between spread of the residuals for linearity, and 
looking for no evidence of changes in the variance for homoscedasticity.  The scatter 
plots for this study are available in Appendices G2 to G7.  These give evidence of both 
linearity and homoscedasticity. 
4.5.3 Multicollinearity 
Multicollinearity tests are conducted to prevent problems with statistical significance on 
the regression coefficients (Hair et al., 2007).  The VIF and tolerance tests in this study 
demonstrated that there were no multicollinearity problems residing in the data (see Table 
4.11).  The VIF values for PE, EE, SI, SDO and PV ranged between 1.031 and 1.738, 
which are all below the 5.0 limit specified in Chapter 3.  The tolerance values for the 
variables ranged between 0.575 and 0.970, all of which are greater than the 0.20 
minimum. 
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4.5.4 Multiple Regression Analysis 
The dependent variable BI was regressed on the independent variables PE (H1), EE 
(H2a), SI (H3a), SDO (H4) and PV (H5).  The results gave an R² value of 0.654, but this 
result does not take cognisance of the meditation affects tested later.  The analysis of 
variance, or ANOVA, gives an F value of 24.9, at a significance of p < 0.001.  These 
results are displayed in Table 4.10. 
  Table 4.10: Model Summary 
R R Square Adjusted R Square 
Std. Error 
of the 
Estimate 
        
    
0.808 0.654 0.627 0.601 
    
ANOVA Sum of Squares df 
Mean 
Square F Sig. 
Regression 45.029 5 9.006 24.896 0 
 
The results of the multiple regression analysis indicate that PE had a very strong 
relationship with BI, with an unstandardized beta of 0.798 (p<0.001) and PV had a weak 
relationship with BI with an unstandardized beta of 0.182 (p<0.05).  The relationships 
between EE, SI and SDO and BI were not found to be significant (p>=0.05).  The 
multiple regression results are available in Table 4.11.  The partial regression plots are 
available in Appendices H1 to H5. 
  Table 4.11: Regression model 
          
  B 
Std. 
Error Beta t Sig. Tolerance VIF 
(Constant) 0.005 0.071 
 
0.064 0.949 
  
Performance Expectancy 0.798 0.096 0.791 8.282 0.000 0.575 1.738 
Effort Expectancy -0.186 0.124 -0.134 -1.495 0.140 0.649 1.540 
Social Influence 0.009 0.074 0.010 0.122 0.903 0.810 1.235 
Social Dominance 
Orientation 
0.076 0.078 0.071 0.972 0.335 0.970 1.031 
Price Value 0.182 0.091 0.164 1.997 0.049 0.778 1.285 
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4.5.5 Mediating Effects 
The tests for the mediating effect of PE on the relationships between BI and EE (H2b), BI 
and SI (H3b) and BI and Trust (H6) were conducted as laid out by Baron & Kenny 
(1986).  These steps are (1) to test individual regression between the mediator onto the 
mediated independent variable; (2) to test regression between the dependent variable and 
the mediated variable, and then (3) to test regression between the dependent variable and 
the other variables combined.  Should the first two tests have statistical significance, and 
the 3rd test have significance only for the mediator and dependent, then the mediated 
relationship will be supported.   
The mediating effect of PE on the relationship between BI and EE is demonstrated by the 
following test results.  Table 4.12 shows that PE and BI are significantly related, and EE 
and BI are significantly related, but when BI is regressed on PE and EE together there is 
no longer a significant relationship between BI and EE (Sig. > 0.05).  This indicates that 
PE provides a mediating relationship between BI and EE. 
Table 4.12: The mediation effect of PE on the relationship between BI and EE
Step Regression Variable B Std. Error Beta t Sig. 
   0.795 0.074 0.788 10.692 0.000 
	   0.479 0.155 0.347 3.091 0.003 





 0.841 0.087 0.833 9.658 0.000 
 -0.122 0.119 -0.088 -1.020 0.311 
 
Table 4.13 displays the results from each step of the testing process which shows that PE 
provides a mediating effect on the relationship between BI and SI.  In the final step SI 
does not have a significant relationship with BI (Sig. > 0.05). 
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Table 4.13: The mediation effect of PE on the relationship between BI and SI
Step Regression Variable B Std. Error Beta t Sig. 
           0.795 0.074 0.788 10.692 0.000 
           0.293 0.105 0.317 2.798 0.007 


      
     
   0.781 0.080 0.774 9.744 0.000 
   0.035 0.073 0.038 0.473 0.638 
 
The mediating effect of PE on the relationship between Trust and BI followed was 
confirmed by the results in Table 4.14.  Both PE and Trust have significant relationships 
with BI, but when tested together, Trust no longer had a significant relationship with BI 
(Sig. > 0.05). 
 
Table 4.14: The mediation effect of PE on the relationship between BI and Trust
Step Regression Variable B Std. Error Beta t Sig. 
           0.795 0.074 0.788 10.692 0.000 

    
     
      0.586 0.110 0.539 5.316 0.000 
       
        
   0.785 0.109 0.752 7.195 0.000 
       0.033 0.114 0.030 0.292 0.772 
 
4.6 Hypotheses Test Results 
4.6.1 The Relationship between Performance Expectancy and Behavioural Intention 
Hypothesis H1 supported. 
 
Performance Expectancy (PE) was hypothesised to be positively related to Behavioural 
Intention (BI).  The correlation analysis indicated a very strong, positive relationship of 
0.788 (p<0.001) between PE and BI.  In the presence of the other factors, PE was still 
shown to have a very strong, positive relationship of  = 0.798 (p<0.001) with BI.  This 
indicates support for H1. 
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4.6.2 The Relationship between Effort Expectancy and Behavioural Intention 
Hypothesis H2a not supported. 
 
H2a proposed that Effort Expectancy (EE) would be positively related to Behavioural 
Intention (BI).  The correlation analysis showed a moderate, positive relationship of 
0.347 (p<0.01) between EE and BI.  In the presence of the other factors, however, EE 
was shown to have no significant relationship with BI.  This suggests a lack of support 
for H2a. 
4.6.3 The Mediating Effect of Performance Expectancy on the Relationship between 
Effort Expectancy and Behavioural Intention 
Hypothesis H2b supported. 
 
H2b proposed that the relationship between Effort Expectancy (EE) and Behavioural 
Intention (BI) would be mediated by Performance Expectancy (PE).  Using Baron & 
Kenny’s (1986) method, PE was shown to mediate the relationship between EE and BI, 
indicating support for H2b. 
4.6.4 The Relationship between Social Influence and Behavioural Intention 
Hypothesis H3a not supported. 
 
H3a proposed that Social Influence (SI) would be positively related to Behavioural 
Intention (BI).  Correlation analysis showed a moderate, positive relationship of 0.317 
(p<0.01) between SI and BI.  In the presence of the other factors, however, EE was 
shown to have no significant relationship BI.  This indicates a lack of support for H3a. 
4.6.5 The Mediating Effect of Performance Expectancy on the Relationship between 
Social Influence and Behavioural Intention 
Hypothesis H3b supported. 
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H3b proposed that the relationship between Social Influence (SI) and Behavioural 
Intention (BI) would be mediated by Performance Expectancy (PE).  H3b was supported 
because PE was confirmed as a mediator of the relationship between SI and BI. 
4.6.6 The Relationship between Social Dominance Orientation and Behavioural 
Intention 
Hypothesis H4 not supported. 
 
H4 proposed that Social Dominance Orientation (SDO) would be negatively related to 
Behavioural Intention (BI).  No significant correlation was found between SDO and BI, 
and multiple regression showed no significant relationship between SDO and BI in the 
presence of other the other factors.  This indicates that the data gives no support for H4. 
4.6.7 The Relationship between Price Value and Behavioural Intention 
Hypothesis H5 supported. 
 
Price Value (PV) was hypothesised to be positively related to Behavioural Intention (BI).  
The correlation analysis indicated a moderate-to-strong, positive relationship of 0.442 
(p<0.001) between PV and BI.  In the presence of the other factors, PV was shown to 
have a weak, positive relationship of  = 0.182 (p<0.05) with BI.  This demonstrates 
support for H5. 
4.6.8 The Mediating Effect of Performance Expectancy on the Relationship between 
Trust and Behavioural Intention 
Hypothesis H6 supported. 
 
H6 proposed that the relationship between Trust and Behavioural Intention (BI) would be 
mediated by Performance Expectancy (PE).  PE was shown to be a mediator of the 
relationship between Trust and BI, which indicates support for H6. 
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4.7 Chapter Summary 
This chapter described the nature of the data and the statistical analysis to test the 
hypotheses.  Most respondents had an intention to use e-prescribing systems, but only 
two factors were directly linked to behavioural intention.  These were Performance 
Expectancy and Price Value.  Performance Expectancy played a mediating role between 
Behavioural Intention, Effort Expectancy, Social Influence and Trust.  Effort Expectancy, 
Social Influence and Social Dominance Orientation had no direct relationship with 
Behavioural Intention, and thus their related hypotheses (H2a, H3a and H4 respectively) 
were not supported.  All other hypotheses were supported.  The summary of the 
hypotheses testing is available in Table 4.15. 
 

Table 4.15: Summary of hypotheses and results 
  

Hypothesis Result 
 

H1: Performance Expectancy will be positively related to Behavioural Intention Supported 

H2a: Effort Expectancy will be positively related to Behavioural Intention Not 
supported 

H2b: Performance Expectancy will mediate the relationship between Effort Expectancy and 
Behavioural Intention Supported 

H3a: Social Influence will be positively related to Behavioural Intention Not 
supported 

H3b: Performance Expectancy will mediate the relationship between Social Influence and Behavioural 
Intention Supported 

H4: Social Dominance Orientation will be negatively related to Behavioural Intention Not 
supported 

H5: Price Value will be positively related to Behavioural Intention Supported 

H6: Performance Expectancy will mediate the relationship between Trust and Behavioural Intention Supported 

Although the response rate was not as high as expected, the very good factor analysis and 
internal validity and reliability results suggested that the sample size was sufficient for 
statistical analysis.  This may be a result of using previously tested items with strong 
content validity.   
The next chapter will discuss the results of the statistical analysis of this chapter, and will 
link these results to literature and the stated hypotheses.  
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CHAPTER 5:   DISCUSSION 
5.1 Chapter Introduction 
This chapter reviews and discusses the results of the statistical tests conducted in the 
previous chapter.  These discussions aim to give insight to the results, reflecting on the 
original hypotheses and the literature which supported them.  Hypotheses which are not 
supported are investigated in order to explain the reason for the failure to support.   
 
This chapter proceeds by first reviewing the study objective, then discussing the results of 
the various hypotheses. 
5.2 Study Objective 
The aim of the study was to investigate the factors supporting physicians’ intention to use 
e-prescribing systems.  A review of literature identified Performance Expectancy (PE), 
Effort Expectancy (EE), Social Influence (SI), Social Dominance Orientation (SDO) and 
Price Value (PV) as potential factors of Behavioural Intention (BI), with EE, SI and Trust 
being mediated factors of BI. 
5.3 Hypotheses 
5.3.1 The Effect of Performance Expectancy upon Behavioural Intention 
Hypothesis H1 supported. 
 
Performance Expectancy (PE) was hypothesised to be positively related to Behavioural 
Intention (BI).  Correlation and multiple regression analysis support this hypothesis.  This 
result corroborates prior e-prescription acceptance research (Boonstra, 2003; Pare et al., 
2006; Tamblyn et al., 2006), and is consistent with the UTAUT model where PE has a 
positive relationship with BI (Venkatesh et al., 2003).  The very strong relationship 
shown between PE and BI, whether in isolation or in the presence of other factors, 
suggests that PE is a very important factor in physicians’ intentions to use e-prescribing 
systems.  These results support previous studies which indicated that e-prescribing 
systems should chiefly be used due to the expected improvement in the quality of 
prescribing and dispensing of medicine (e.g. Kaushal et al., 2010; Devine et al., 2010).   
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These results further indicate that e-prescribing systems have not yet been adopted where 
the benefits are not immediately apparent. 
5.3.2 The Effect of Price Value upon Behavioural Intention 
Hypothesis H5 supported. 
 
The monetary cost of the system was proposed as a factor of intention when Price Value 
(PV) was hypothesised in this study to be positively related to Behavioural Intention (BI).  
This hypothesis was supported by the data through correlation analysis and multiple 
regression analysis.  This result supports suggestions that the monetary cost of an e-
prescribing system may deter physicians from using it (Crosson et al., 2011; Smith, 2006; 
Halamka et al., 2006), much like the monetary cost has been suggested to be preventative 
in other contexts (e.g. Venkatesh, 2012).  The results are also consistent with the Product 
Evaluation Model of Dodds et al. (1991), which postulates that a product is more likely to 
be used when the perceived value outweighs the monetary cost.   
 
PV was positively related to BI, even when in the presence of other variables, although it 
had a weaker relationship with BI than PE had with BI.  This supports the argument that 
PV is a very pertinent factor in physicians’ intentions to use e-prescribing systems, albeit 
a less pertinent factor than PE.   
 
Based on PV’s effect on BI in the context of physician’s adoption of e-prescribing, PV 
could be an important factor to focus on to encourage the use of e-prescriptions.  In order 
to achieve this, providers would need to control system prices to keep them at a 
reasonable level, providers could selectively subsidise the costs depending on inter-
physician shared usage (Ozdemir, Barron & Bandyopadhyay, 2011) or alternatively 
government organisations could give financial support and incentives to cover these 
system costs, as suggested by (Crosson et al., 2011).   
5.3.3 Mediated Effects 
Davis et al. (1989) argue that Performance Expectancy (PE) should provide a foundation 
for studying the impact of external variables.  This study demonstrates PE’s ability to 
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provide a foundation for other variables (Davis et al., 1989), specifically in the e-
prescribing context with Trust, Social Influence and Effort Expectancy.  It was 
demonstrated in this study that the relationships between BI and the three variables of 
Effort Expectancy, Social Influence and Trust were mediated by Performance 
Expectancy.   
  
Hypothesis H2b supported. 
 
The first variable mediated by PE was Effort Expectancy.  This mediated relationship is 
consistent with expectations based upon the various TAM models (Davis, 1989; 
Venkatesh & Davis, 2000; Venkatesh & Bala, 2008).  It was argued earlier in this study 
that any difficulty in using e-prescription systems may prevent the expected benefits of e-
prescriptions from being realised.  The results of this study support this view, 
demonstrating that the degree of ease of using a system may have an effect on the 
expected performance of e-prescribing systems. 
These results suggest that while performance expectancy appears to be the most 
important factor leading to intention, effort expectancy cannot be ignored, especially as 
performance expectancy may be affected by effort expectancy itself.  Some studies found 
that capturing e-prescriptions took considerably longer than writing up a prescription 
(Eslami et al., 2007; Devine et al., 2010).  Such challenges would need to be looked at 
through the design of the system, to allow for speedy and unobtrusive use in the 
consultation room.  
Hypothesis H3b supported. 
 
Social Influence (SI) was hypothesised to be related to Behavioural Intention (BI) 
through the mediating effect of Performance Expectancy (PE).  This hypothesis was 
supported by the data.  This result is consistent with expectations based upon acceptance 
literature indicating that SI’s relationship with BI may be mediated by PE (Venkatesh & 
Bala, 2008; Venkatesh & Davis, 2000).  One’s perception of the usefulness of an e-
prescribing system may be enhanced or reduced by influence brought upon by important 
others.  The relationship between SI and PE is highlighted as the highest relationship that 
SI has with any of the variables in isolation.  This could indicate that social forces may 
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best influence a physician’s adoption of e-prescriptions by focussing on the improvement 
in performance brought about by these systems.  
 
SI relates better with PE than it relates to any of the other variables, which could be 
indicative of the impact that social influence has on the expected performance 
improvements brought about through using e-prescribing systems.   
 
Hypothesis H6 supported. 
 
H6 predicted that the relationship between Trust and Behavioural Intention (BI) would be 
mediated by Performance Expectancy (PE).  This hypothesis was supported by the data. 
This finding adds support to literature which intimated that lowered trust in an e-
prescribing system may be a hindrance to the use of e-prescribing systems (Smith, 2006; 
van der Sijs et al., 2006; Crosson et al., 2011).   It also supports the inclusion of Trust as a 
factor leading to physicians’ adoption of e-prescribing systems.  The strong relationship 
between Trust and PE, leading on to BI, indicates the important role that trust plays for 
physicians in the adoption of e-prescribing systems.  Based on this, one could say that a 
physician would not adopt an e-prescribing system unless the physician trusts that it can 
deliver upon its expectations, even if those expectations are about performance benefits.  
In the medical field it is relevant to trust the systems, where a patient’s health, or life, is 
dependent on the accuracy of the system’s results and process. 
This indicates that the confidence of physicians in the reliability of e-prescribing systems 
should lead to improved adoption of such systems. 
Trust also has strong, positive relationships with BI, PE, EE and PV, with the strongest 
relationship being with PE.  It is interesting that the Trust in a system is so closely linked 
with other perceptions of use and value of the system, indicating the high relevance of 
Trust to other factors of adoption.  Just as Trust in a system’s reliability could lead to 
improved adoption of such systems, so it may also be that Trust in a system’s reliability 
may be linked with the effort and time required to use a trustworthy system, and the 
perceived value of a trustworthy system in relation to its cost. 
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5.3.4 The Effect of Effort Expectancy upon Behavioural Intention 
Hypothesis H2a not supported. 
 
It was anticipated that Effort Expectancy (EE) would be positively related to Behavioural 
Intention (BI).  Correlation analysis initially supported this hypothesis, which 
corroborated prior e-prescription acceptance research (Boonstra, 2003; Pare et al., 2006; 
Tamblyn et al., 2006).  Multiple regression analysis, however, did not corroborate the 
correlation analysis, and thus the hypothesis was not supported.   
 
It was unexpected to find that EE did not have a relationship with BI when in the 
presence of other factors, such as PE.  This finding was unexpected because the 
hypothesised relationship had been supported in previous studies, including being integral 
to the UTAUT model of Venkatesh et al. (2003), and other acceptance models such as 
TAM (Davis, 1989).  Furthermore, EE was shown to be a factor of BI in the presence of 
PE within the medical context by a number of previous studies (Holden & Karsh, 2009).   
 
The result in the current study could be owing to the very strong impact that PE has on 
BI.  This would be due to any performance improvement brought about by electronic 
prescriptions being much more important than any perceived difficulty in using the 
system.  Much like this study, other studies have also found that EE does not consistently 
have a direct effect on intention: the reason for this is argued to be a consequence of the 
purpose of the system itself (Gefen & Straub, 2000).  This view of EE’s role in adoption 
suggests that where the purpose of the system is to obtain and generate a product (such as 
a prescription of medicine), rather than where the purpose of the system is to create 
awareness of a product (such as obtaining product information), then EE will not have a 
direct effect on adoption of that system (Gefen & Straub, 2000).  In the case of e-
prescribing, the electronic prescription itself is the valued product, rather than 
information about the prescription, and thus Gefen & Straub’s (2000) view of adoption 
could explain why EE had no direct effect on intention in this study. 
 
Alternatively, the result in this study could be a consequence of varying degrees of 
experience of the respondents on the e-prescribing systems.  This is due to suggestions 
that the significance of EE diminishes with increasing experience of the users (Venkatesh 
 62 
 
et al., 2003).  This study did not measure experience based on previous studies in the e-
prescribing context finding that experience had no moderating effect on EE (Wang et al., 
2009). 
5.3.5 The Effect of Social Influence upon Behavioural Intention 
Hypothesis H3a not supported. 
Social Influence (SI) is described as the level to which the participant believes others, of 
perceived importance to the participant, believe the system should be used (Venkatesh et 
al., 2003).  Within the context of e-prescribing, prior literature proposed that SI may be a 
factor in the context of physicians’ use of e-prescribing systems (Boonstra, 2003).  This 
current study demonstrated that SI does indeed have a relationship with BI when tested in 
isolation. This result supports prior e-prescription acceptance research (Simon et al., 
2009; Fischer et al., 2007), which suggested that social influence would affect a 
physician’s intention to use e-prescribing.   
 
When compared to other factors, however, SI was found to have no relative importance 
in explaining BI.  This is contrary to the UTAUT model of Venkatesh et al. (2003), which 
predicts that SI will have a relationship with BI, even in the presence of other factors like 
PE.  A potential explanation for this unforeseen result, much like with EE, is that in the 
presence of PE’s very strong effect on BI, SI would not have a direct effect on BI.  This 
could indicate that the influence of significant others would not have a direct bearing on a 
physician’s intention to use e-prescribing where there already exists an expectation of 
improved performance through the system.  
5.3.6 The Effect of Social Dominance Orientation upon Behavioural Intention 
Hypothesis H4 not supported. 
 
Social Dominance Orientation (SDO) was proposed to be negatively related to 
Behavioural Intention (BI).  No support for this hypothesis was found through correlation 
analysis or multiple regression analysis.  
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This result was not anticipated due firstly to literature suggesting that physicians are 
likely to have high levels of SDO (Freidson, 2007), and secondly to literature suggesting 
that individuals with high levels of SDO, are less likely to adopt new innovations 
(Sidanius & Pratto, 1999).  It should thus have followed that physicians would be less 
likely to adopt e-prescriptions where they had higher levels of SDO.  The lack of support 
for this hypothesis may indicate a weakness in the theorising which led to the suggested 
relationship between SDO and BI.   
 
SDO was not found to be related to SI.  This is surprising as SDO could have had a 
negative relationship with SI.  This was expected because SI is the positive influence 
brought about by important others, and SDO is the negative influence brought about by 
un-important others.   
 
The unanticipated results in this study could be explained by the neutral responses given 
by respondents for the SDO variable.  The neutral SDO level of physicians measured in 
this study is contrary to Freidson’s (2007) assertion of a higher than neutral SDO level 
among physicians.  The very neutral response, in contrast to literature’s predictions, could 
indicate that the SDO responses given in this study were tempered by respondents, based 
on the sensitivity pertaining to stigma of other groups of people.  During the pre-tests of 
this study the sensitive nature of the questions was raised as a concern, and an attempt 
was made to lower the tone of any overtly worded items.  Further tempering of the 
answers on these questions by respondents may have negatively affected the explanative 
ability of the results obtained, such that any theorised relationship between SDO and BI 
would consequently not be found. 
5.4 Chapter Summary 
This chapter investigated and discussed the results of the survey in relation to the 
theoretically based hypotheses.   
 
Performance Expectancy was found to have a major bearing on the intention to use e-
prescribing systems, and should be an area of focus in design of e-prescribing systems.  
Should the system not cater for the operational needs of e-prescriptions, and bring 
improved performance, it is unlikely that the systems will be used.  Price Value was also 
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found to be a direct factor of intention, indicating that the cost of using e-prescribing 
systems should be controlled or subsidised to enable their use. 
 
Effort Expectancy, Social Influence and Trust were found to have an effect through 
performance expectancy on physicians’ intention to use e-prescription systems.  Effort 
Expectancy thus shows that the usability of an e-prescribing system affects a physician’s 
perceptions of the performance gain from the system.  Social Influence demonstrates that 
others who are important to a physician can influence that physician’s expectation of the 
performance of the system, and consequently its use.  Trust indicates that a physician’s 
confidence in the system delivering intended results affects the physician’s expectations 
of improved performance through the system. 
 
Social Dominance Orientation was not found to have an effect on intention.  This may be 
due to a weakness in the theorising which hypothesised the relationship between SDO 
and BI, but there are indications that the responses on those questions may have been 
tempered by the respondents to a more neutral result.  This could make way for an 
alternative study to retest this factor under different conditions to encourage less 
restrained results. 
 
The next chapter will conclude and summarise the study, highlighting contributions to 
theory and practice, and will make suggestions for future research. 
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CHAPTER 6:   CONCLUSION 
6.1 Chapter Introduction 
This chapter concludes the report by giving an overview of the objectives and findings of 
the study.  The contributions made by the study to practice and to theory are discussed, 
and the limitations of the study are described. The chapter ends with opportunities for 
further research based on the findings of this study, followed by concluding remarks. 
6.2 Summary of Objectives 
This study aimed to examine factors which support physicians’ intentions to use e-
prescribing systems.  Prior research suggested that Performance Expectancy and Effort 
Expectancy were factors of intention, but these two factors on their own were not 
sufficient to explain physicians’ intention to use e-prescribing systems (Boonstra, 2003).  
This study consequently investigated additional factors supporting physicians’ intention 
to use E-prescribing Systems, which were Social Influence, Social Dominance 
Orientation, Price Value and Trust, along with the original Performance Expectancy and 
Effort Expectancy factors.  This was done to investigate the following problems:  
To what extent does: 
• The perceived change in performance from e-prescribing affect physicians’ 
intention to use an e-prescribing system?  
• The perceived usability of an e-prescribing system affect physicians’ intention to 
use such a system?  
• The degree to which a physician is socially influenced to use an e-prescribing 
system affect the physician’s intention to use such a system?  
• The degree to which a physician is social dominance orientated affect the 
physician’s intention to use an e-prescribing system?  
• The perceived price value of an e-prescribing system affect physicians’ intention 
to use such a system?  
• The perceived change in performance mediate the relationship between perceived 
usability and physicians’ intention to use the system?  
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• The perceived change in performance mediate the relationship between social 
influence and physicians’ intention to use the system?  
• The perceived change in performance mediate the relationship between 
confidence in the system’s reliability and physicians’ intention to use the system? 
 
Data was collected using a structured, online survey, from physicians which had exposure 
to e-prescribing systems.  72 usable results were collected. 
6.3 Summary of Key Findings 
6.3.1 Main Findings 
The study found that Performance Expectancy was very closely associated with 
Behavioural Intention, suggesting that the expected performance of e-prescriptions would 
be the driving factor leading to use of the system.  Price Value was found to have a direct 
relationship with intention, even in the presence of Performance Expectancy.  This was 
suggestive of the importance of the perceived cost benefit of an e-prescribing system in 
physicians’ decision to make use of it.  Trust in technology was found to have an indirect, 
mediated relationship with Behavioural Intention.  This relationship was mediated 
through performance expectancy.  Social Dominance Orientation was found to have no 
direct relationship with intention, whether in isolation or in the presence of other 
variables.   
 
Previous studies in the e-prescribing context found that Effort Expectancy also had an 
effect on Behavioural Intention.  This study, however, found that Effort Expectancy did 
not have a direct effect on intention to use, when in the presence of Performance 
Expectancy.  Instead, Effort Expectancy had an indirect relationship with Behavioural 
Intention through Performance Expectancy.  Social Influence also did not have the 
expected direct relationship with Behavioural Intention when in the presence of other 
variables, but it did have an indirect relationship with Behavioural Intention when 
mediated by Performance Expectancy. 
6.3.2 Summarised Interpretation of the Findings 
The findings from this study suggest that in order to improve physicians’ intentions to use 
e-prescribing systems, the systems need to be designed to best improve the performance 
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of the physician, rather than exclusively on the patient or pharmacist. This may be 
through improving the speed of interaction, shortened patient recovery periods, and the e-
prescriptions would need to save the physician time through less call backs from 
pharmacists.  The price of the system would also need to be kept low, in relation to the 
value of the system, or alternatively government financial support could be given to 
physicians for using e-prescriptions.  It appears that for as long as physicians are 
responsible for the cost of e-prescribing systems, the price will be a sensitive point.   
 
Additional attention should be given to supporting expectations of improved performance 
by making the system easy to use, thus lowering the obtrusiveness of the system to the 
health care process.  E-prescribing systems need to be, and be seen to be, stable and to be 
able to perform as expected.  Furthermore, relevant industry councils or educators can 
encourage the use of e-prescribing systems by ensuring such systems are promoted 
throughout the industry. 
6.4 Contribution to Practice 
6.4.1 Main Implications to Practice 
This study demonstrated the importance of having an e-prescribing system instead of 
written prescriptions. Physicians, however, have traditionally used written prescriptions 
as standard practice.  In order to introduce an e-prescribing system to the prescribing 
process, such a system would need to add new value to physicians, without impacting 
their existing ability to interact and treat their patients. Simply producing a list of ways e-
prescribing benefits the patient or pharmacist might not be sufficient, as the system would 
need to enable the physicians themselves to perform their jobs quicker, more effectively 
and with better results.  The introduction of enhanced e-prescribing systems can also 
unlock new benefits for physicians, such as checking for drug incompatibility, or 
displaying a full list of drug side-effects without a physician having to commit them to 
memory.  These additional benefits should also be presented to persuade physicians to 
use e-prescribing systems, as they benefit the physician directly. 
 
E-prescribing systems need to be reasonably priced for physicians, as these professionals 
currently need to carry the cost.  This could be difficult if the technology is new and 
struggling to get sufficient buy-in from potential users, where the income generated from 
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use of the system cannot support the developers of the system.  Further costs may be 
encountered in establishing necessary infrastructure to support e-prescribing systems, 
such as access to the Internet and hardware acquisition, where physicians don’t currently 
have these in place.  In order to both lower the costs to the physicians and support the 
system vendors, governmental support would be required.  Governmental support would 
be through the form of subsidies for physicians who use the system.  This would not only 
encourage physicians to use the systems, but would also support system vendors through 
the increased use of e-prescriptions.  Based on the potential for improved medical care 
and lessened prescription errors, it would be beneficial to government if they gave this 
financial support, due to with the expectation of lowered mortality rates and long term 
financial savings unlocked by the improved medical care. 
6.4.2 Additional Implications to Practice 
Three further areas are highlighted to assist in improving, or supporting, physicians’ 
perceptions of increased performance from e-prescriptions. The first area is trust in the 
system, where system design should ensure the stability, accuracy, responsiveness and 
reliability of the systems.  This requires a stable system which is tested to achieve a high 
level of quality, with system errors and gaps ironed out, to ensure that what is captured by 
the physician is what is presented to the pharmacist.  Furthermore the system should be 
stand-alone, being able to function even if the connection to the Internet is not 
immediately available.  If physicians do not have this trust in the systems, in that they are 
uncertain of the consistency of the performance of these systems, they will be less likely 
to use them.   
 
The second area to focus on is the usability of the system.  This can be achieved through 
sufficient system and process design to make the e-prescribing interface unobtrusive, 
such as being used on a tablet PC instead of a desktop PC, and for the interface of the 
system to be intuitive and streamlined with a least-click approach.  Should the physician 
be struggling to use functionality it is likely that they won’t achieve the performance 
benefits expected, and would revert to hand written prescriptions.   
 
The third area of focus is the social influence of colleagues and others in the industry. 
This study indicated that social influence can improve the likelihood of physicians 
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perceiving that e-prescribing will be of benefit to them, and consequently should be more 
likely to begin using e-prescription systems.  This could be achieved through conferences 
where fellow physicians present and demonstrate such systems, and how useful the 
systems can be when used in practice.  
6.5 Contribution to Theory 
This study contributes to the existing body of knowledge in the context of the adoption of 
e-prescription systems.  This area of study has not been extensively explored.  The 
majority of the previous studies comprised case studies and descriptive analysis studies, 
with only a few studies exploring the factors leading to improved adoption of e-
prescriptions.  Those which did investigate adoption focussed on performance expectancy 
and effort expectancy (Wang et al., 2009; Tamblyn et al., 2006; Pare et al., 2006; 
Boonstra, 2003).  This current study went further than previous studies by supporting 
additional factors of physicians’ adoption of e-prescribing systems, thus expanding and 
enriching the current knowledge in this context.  These supported factors were Social 
Influence, Trust and Price Value. 
 
The Unified Theory of Acceptance and Use of Technology, or the UTAUT model, was 
extended in this study with the Commitment-Trust Theory, the Product Evaluation Model 
and Social Dominance Theory.  The empirical tests in this study demonstrate a new, 
successful combination of UTAUT, Commitment-Trust Theory and the Product 
Evaluation Model in the process of explaining physicians’ intention to use e-prescribing 
systems.  This combination of theories would add to future studies where potential users 
of systems are those who have to pay for the use of the systems, or where users’ 
confidence in a system’s expected behaviour is important to their particular decision to 
use the system.   
 
Effort Expectancy, normally a reliable factor leading to adoption, was not a direct factor 
of intention when used in the combination of UTAUT and the Product Evaluation Model, 
and within the context of physicians’ adoption of e-prescriptions.  This presented an 
interesting perspective as to the impact of Effort Expectancy on Behavioural Intention 
when the system in question is not the final product itself. 
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The inclusion of Social Dominance Orientation (SDO), taken from Social Dominance 
Theory, presented a new area of learning in adoption studies.  Literature suggests that 
SDO has an effect on intention to use, or adopt, a new system.  The results in this study 
showed that SDO needs further research and theorising in order to find its place in 
adoption based research, if at all.  Certain limitations in this study should also guide 
future researchers to an improved survey approach to encourage less tempered responses 
for SDO based variables. 
6.6 Limitations of the Study 
This study makes claims based on previous literature and empirical tests.  Certain 
limitations in this study may cause certain results to be viewed with caution.   
6.6.1 Sampling Limitations 
The response sample was limited in three ways.  Firstly it was restricted to physicians 
who had access to email and the Internet, and were available either through an existing 
medical software provider, or through public online records.  The broad approach within 
these data sources may counteract the limitations to some degree, but the results may not 
be generalisable due to this limitation.  The second limitation is the smaller response size, 
being 72 usable responses.  Notwithstanding the statistical reliability and validity of the 
data, this small response sample may have affected the degree to which the results could 
be generalisable. 
6.6.2 Methodological Limitations 
Using a quantitative approach is limited in that it does not consider intangible factors 
such as the respondent’s mood or emotional state whilst filling out the survey.  A 
qualitative approach would have allowed a further exploration of physicians’ intentions 
and perceptions of e-prescriptions.  A qualitative approach does not, however, measure 
the relative strengths of the variables, which consequently required a quantitative 
approach in this study to test the modified model.   
 
Based on the responses, the majority of the respondents had an intention to use e-
prescribing systems already.  This might indicate a response bias where most respondents 
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chose to respond due to their current use or intended use of e-prescribing systems, rather 
than a general response of all potential users.  The questionnaire contains all variables in 
the research, being captured by the same person at the same time, which may create a 
common method bias.  The method of collecting the sample, through specific databases, 
may allow for a sample bias, where the sample is limited based on the collection 
delimitations. 
 
This study makes use of a cross-sectional survey, where the independent and dependent 
variables are measured at the same point in time, which can make it difficult to infer 
causality in the relationships (Bhattacherjee, 2012).  This can be mitigated through causal 
inferences of the relationships being based upon the underlying theories predicting the 
correlations. 
6.6.3 Contextual Limitations 
The study was conducted in the South African context which may limit the 
generalisability of the results.  It is possible that South African respondents are more 
sensitive to SDO based questions, thus limiting the effectiveness of the SDO variable, 
due to the changing social identification found in Postapartheid South Africa (Bornman, 
2010).  The low response ratios may have been due to potential respondents in South 
Africa being unaccustomed to being contacted for social science research (Department of 
Higher Education and Training, 2012). 
6.6.4 Limitations of the Model 
The proposed model had support for most of its proposed relationships, but the model 
might have excluded alternative factors, which could have had relevance and value in this 
study.  The risk of this was mitigated by literature review within the adoption and e-
prescribing contexts.  The model was further limited by making use of Behavioural 
Intention as a proxy for actual use.  While literature supports this approach, the actual 
adoption of e-prescribing systems by physicians was not directly tested. 
 
Given that the hypotheses were constructed from literature, and most of these were 
supported by data, it is likely that the limitations in the study did not overtly undermine 
the results.   
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6.7 Opportunities for Further Research 
A number of opportunities for further research are suggested as a result of the conclusion 
of this study.  Due to limitations in the empirical testing, further studies may aim to 
corroborate the claims of this current study, in the same context, by collecting larger data 
sets across broader groups of physicians, with the aim of improved generalisability of the 
results.  This may be achieved through studies which pay respondents to respond.  These 
have resulted in higher response rates, e.g. Wang et al. (2009) who paid $100 per 
response and got a response rate close to 60%.  
 
Further studies in this context may aim to measure other factors leading to physicians’ 
use of e-prescribing systems, such as the physician’s exposure to e-prescribing systems 
during medical education and training.  This sort of study would need to measure the 
intentions of physicians who had used e-prescription systems as part of their studies and 
training.  This study may only be currently possible in regions where e-prescriptions are 
already part of medical training. 
 
Future research would have an opportunity of using this study’s model in different 
contexts, such as those where users of systems are required to pay for its use to test Price 
Value (e.g. non-organisational studies), or alternatively studies where underperformance 
of the system is a critical issue to test Trust (e.g. other medical or safety based systems). 
 
While the proposed role of SDO was not supported in this study, further research may 
identify SDO’s role in adoption or resistance to change, where other variables not 
explored in this study may control for, or be affected by SDO. A potential solution to this 
is to conduct such studies in the USA where previous studies achieved less tempered, 
more meaningful results from their SDO responses (e.g. Ho et al., 2012). 
6.8 Conclusion 
E-prescriptions have been proposed as a viable solution to the high rates of patient health 
complications and deaths from incorrectly prescribed or incorrectly dispensed medication 
(Tamblyn et al., 2006; Ammenwerth et al., 2008; Devine et al., 2010).  Despite the 
benefits of e-prescription systems, there has been little research into the factors which 
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lead to the adoption of these systems.  This study contributes to the understanding of 
factors leading to physicians’ adoption of e-prescribing systems.  
 
The study conducted a survey of South African physicians with exposure to e-
prescriptions.  The results of the survey indicated that the expected gain in performance 
from using e-prescription systems was a strong driver of the use of these systems.  
Furthermore, the cognitive trade-off between the pricing and the perceived value of the 
system was also found to be a driver of the intended use of the system.  The results of this 
study also demonstrated that the expected performance benefit of using e-prescriptions 
was affected by the physician’s trust in the system, or confidence in the reliability of the 
system, along with the ease of use of the system and social influence regarding the 
usefulness of the system.   
 
Based on the findings of this report, there are various factors, over and above 
Performance Expectancy and Effort Expectancy, which should be areas of focus to 
encourage physicians’ use of e-prescribing systems.  These additional factors tell us that a 
collaborative effort is required from software vendors, government and medical councils 
to provide quality systems, financial support and social impetus for an accelerated change 
from written to electronic prescriptions.  This collaboration around e-prescriptions has 
begun in the European Union where it has become strategic policy (Kierkegaard, 2013), 
and similar energies would be required in other regions, such as South Africa. Given the 
patient deaths and extended illnesses resulting from written prescription errors and 
illegibility, considerable effort should be placed on putting e-prescribing systems into 
meaningful use for the benefit of all patients.   
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CHAPTER 8:   APPENDIX 
13.1 Appendix A: List of Items and Sources 
 
Item 
Num. Items Variable Items Source 
BI1.   
BI2.   
BI3. 
- I intend to use e-prescriptions, given the opportunity 
- I predict I would use e-prescriptions, given the opportunity 
- I plan to use e-prescriptions, given the opportunity 
Behavioural 
intention Venkatesh et al. (2003) 
PE1. 
 
PE2.   
PE3.   
PE4.   
PE5.   
PE6. 
- Using e-prescriptions in my job would enable me to accomplish tasks 
more quickly 
- Using e-prescriptions would improve my job performance 
- Using e-prescriptions in my job would increase my productivity 
- Using e-prescriptions would enhance my effectiveness on the job 
- Using e-prescriptions would make it easier to do my job 
- I would find e-prescriptions useful in my job 
Performance 
Expectancy Davis (1989) 
EE1. 
EE2.  
EE3.   
EE4. 
EE5.  
EE6. 
- Learning to operate e-prescriptions would be easy for me 
- I would find it easy to get e-prescriptions to do what I want it to do 
- I would understand how to interact with e-prescriptions 
- I would find e-prescriptions to be flexible 
- It would be easy for me to become skilful at using e-prescriptions 
- I would find e-prescriptions easy to use 
Effort 
Expectancy Davis (1989) 
SI1. 
 
SI2. 
SI3. 
- People who influence my behaviour think that I should use e-
prescriptions 
- People who are important to me think that I should use e-prescriptions 
- People whose opinions I value think I should use e-prescriptions 
Social Influence Ajzen (1991) with extra item from Yi et al.  (2006) 
SDO1. 
 
SDO2. 
SDO3. 
.  
SDO4. 
- It's probably a good thing that certain staff are at the top and others 
are at the bottom 
- Certain staff should stay in their place 
- If certain categories of staff stayed in their place, we would have 
fewer problems  
- Sometimes other staff must be kept in their place 
Level of Social 
Dominance 
Orientation 
Pratto et al. (1994), with 
factor analysis from Ho et al. 
(2012) 
T1.  
T2. 
T3.  
T4. 
- I believe e-prescriptions will always meet my expectations 
- I believe e-prescriptions can be counted on to fulfil their function well 
- I believe e-prescriptions will be reliable 
- I believe e-prescriptions cannot always be trusted 
Trust Garbarino & Johnson (1999) 
PV1. 
PV2. 
PV3. 
- E-prescriptions are reasonably priced 
- E-prescriptions is good value for money 
- At the current price, e-prescriptions provide good value 
Price Value Venkatesh, Thong & Xu (2012) 
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13.2 Appendix B: Online Survey 
E-prescribing Questionnaire 
This questionnaire measures your level of agreement towards various elements of e-
prescribing. The first part of the questionnaire, on pages 1 and 2, comprises 25 questions, 
and the second part, on page 3, comprises 4 questions. The final section, on pages 4 and 
5, captures demographic data. There are five pages of questions. For the statements which 
follow, please indicate your level of agreement towards each question by ticking the 
appropriate box among the options available (strongly disagree through to strongly 
agree).  
 
This section deals with your perceptions of e-prescribing.  Please indicate your level of 
agreement towards each question by ticking the appropriate box among the options 
available 
 
  
Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree  
Using e-prescriptions in 
my job would enable me 
to accomplish tasks 
more quickly 
 
     
 
Using e-prescriptions 
would improve my job 
performance        
Using e-prescriptions in 
my job would increase 
my productivity        
Using e-prescriptions 
would enhance my 
effectiveness on the job        
Using e-prescriptions 
would make it easier to 
do my job        
I would find e-
prescriptions useful in 
my job        
Learning to use e-
prescriptions would be 
easy for me        
I would find it easy to 
get e-prescriptions to do 
what I want them to do        
I would understand how 
to interact with e-
prescriptions        
I would find e-
prescriptions to be  
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Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree  
flexible 
It would be easy for me 
to become skilful at 
using e-prescriptions        
I would find e-
prescriptions easy to use  
     
 
 
  
Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree  
I believe e-prescriptions 
will always meet my 
expectations        
I believe e-prescriptions 
can be counted on to 
fulfil their functions 
well 
 
     
 
I believe e-prescriptions 
will be reliable  
     
 
I believe e-prescriptions 
cannot always be trusted  
  
 
 
   
 
e-Prescribing questionnaire - Section 1 - page 2 of 5 
 
This section deals with your perceptions of e-prescriptions.  Please indicate your level of agreement towards 
each question by ticking the appropriate box among the options available 
  
Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree  
e-Prescriptions are 
reasonably priced  
     
 
e-Prescriptions are good 
value for money  
     
 
At the current price, e-
prescriptions provide 
good value        
People who influence 
my behaviour think that 
I should use e-
prescriptions 
 
     
 
People who are 
important to me think 
that I should use e-
prescriptions 
 
     
 
People whose opinions I 
value think I should use 
e-prescriptions        
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Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree  
I intend to use e-
prescriptions, given the 
opportunity        
I predict I would use e-
prescriptions, given the 
opportunity        
I plan to use e-
prescriptions, given the 
opportunity        
 
 
e-Prescribing questionnaire - Section 2 - page 3 of 5 
 
This section deals with your perceptions of people within an organisation. Please indicate 
your level of agreement towards each question by ticking the appropriate box among the 
options available 
  
Strongly 
disagree Disagree Neutral Agree 
Strongly 
agree  
It's probably a good 
thing that certain staff 
are at the top and others 
are at the bottom 
 
     
 
Certain staff should stay 
in their place  
     
 
If certain categories of 
staff stayed in their 
place, we would have 
fewer problems 
 
     
 
Sometimes other staff 
must be kept in their 
place    
 
 
   
 
 
e-Scripting Questionnaire - section 3 - page 4 of 5 
This section captured demographic data. Please tick whichever boxes are applicable to you. 
 
Please indicate your gender: 
•  Female 
•  Male 
 
Please indicate your age: 
•  Less than 30 years old 
•  30-34 
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•  35-39 
•  40-44 
•  45-49 
•  50-54 
•  55-59 
•  60-64 
•  65-69 
•  70 years and older 
 
How did you hear of the e-prescriptions? 
•  Via someone else who is a medical professional 
•  Via someone else who is not a medical professional 
•  Through personal research 
 
Your exposure to e-prescribing systems: 
  
Yes No 
 
I am aware of e-prescriptions 
 
  
 
I understand the process of e-
prescriptions  
  
 
I have been directly exposed to e-
prescriptions  
  
 
I have begun making use of e-
prescriptions  
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13.3 Appendix C: Health-Soft Permission Letter 
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13.4 Appendix D: Ethics Clearance 
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13.5 Appendix E: Survey Cover Letter 
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13.6 Appendix F: Frequency Distribution per Item 
Item 
Strongly 
disagree Disagree Neutral Agree 
Strongly 
Disagree Total Missing 
Behavioural Intention 
BI1 2 5 7 31 27 72 0 
BI2 2 6 6 31 25 70 2 
BI3 3 3 9 30 26 71 1 
Performance Expectancy 
PE1 2 7 10 33 19 71 1 
PE2 3 6 8 34 21 72 0 
PE3 3 9 9 31 20 72 0 
PE4 3 7 11 30 20 71 1 
PE5 3 9 8 29 22 71 1 
PE6 3 2 8 36 22 71 1 
Effort Expectancy 
EE1 1 4 10 32 25 72 0 
EE2 1 4 22 28 17 72 0 
EE3 0 1 12 39 20 72 0 
EE4 2 5 21 31 13 72 0 
EE5 0 2 13 30 25 72 0 
EE6 2 6 12 30 20 70 2 
Social Influence 
SI1 9 18 23 18 4 72 0 
SI2 8 20 24 15 5 72 0 
SI3 8 19 26 13 5 71 1 
Social Dominance Orientation 
SDO1 3 6 21 34 8 72 0 
SDO2 4 18 27 18 5 72 0 
SDO3 8 19 23 17 5 72 0 
SDO4 8 15 25 20 4 72 0 
Price Value 
PV1 2 6 31 24 9 72 0 
PV2 2 5 32 24 9 72 0 
PV3 2 6 30 23 10 71 1 
Trust 
T1 4 17 25 16 9 71 1 
T2 2 6 18 32 14 72 0 
T3 1 4 14 37 16 72 0 
T4 8 25 22 12 5 72 0 
       
  
        
 
Note – The sample size of 72 is based on rows which had three or less incomplete items, and which conformed to the z-scores test. 
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13.7 Appendix G1: P-Plots – Behavioural Intention 
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13.8 Appendix G2: P-Plots and Scatterplots – Performance Expectancy 
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13.9 Appendix G3: P-Plots and Scatterplots – Effort Expectancy 
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13.10 Appendix G4: P-Plots and Scatterplots – Social Influence 
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13.11 Appendix G5: P-Plots and Scatterplots – Social Dominance Orientation 
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13.12 Appendix G6: P-Plots and Scatterplots – Price Value 
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13.13 Appendix G7: P-Plots and Scatterplots – Trust 
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13.14 Appendix H1: Partial Regression Plot – Performance Expectancy 
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13.15 Appendix H2: Partial Regression Plot – Effort Expectancy 
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13.16 Appendix H3: Partial Regression Plot – Social Influence 
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13.17 Appendix H4: Partial Regression Plot – Social Dominance Orientation 
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13.18 Appendix H5: Partial Regression Plot – Price Value 
 
 
